Characterization of Drosophila integrin linked kinase. by Stevens, Marianne
University of Windsor 
Scholarship at UWindsor 
Electronic Theses and Dissertations Theses, Dissertations, and Major Papers 
2004 
Characterization of Drosophila integrin linked kinase. 
Marianne Stevens 
University of Windsor 
Follow this and additional works at: https://scholar.uwindsor.ca/etd 
Recommended Citation 
Stevens, Marianne, "Characterization of Drosophila integrin linked kinase." (2004). Electronic Theses and 
Dissertations. 1400. 
https://scholar.uwindsor.ca/etd/1400 
This online database contains the full-text of PhD dissertations and Masters’ theses of University of Windsor 
students from 1954 forward. These documents are made available for personal study and research purposes only, 
in accordance with the Canadian Copyright Act and the Creative Commons license—CC BY-NC-ND (Attribution, 
Non-Commercial, No Derivative Works). Under this license, works must always be attributed to the copyright holder 
(original author), cannot be used for any commercial purposes, and may not be altered. Any other use would 
require the permission of the copyright holder. Students may inquire about withdrawing their dissertation and/or 
thesis from this database. For additional inquiries, please contact the repository administrator via email 
(scholarship@uwindsor.ca) or by telephone at 519-253-3000ext. 3208. 




Submitted to the Faculty of Graduate Studies and Research 
Through the Department of Biological Sciences 
In Partial Fulfillment of the Requirements for the 
Degree of Master of Science at the 
University of Windsor
Windsor, Ontario, Canada 
2004
© 2004 Marianne Stevens
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1*1 Library and Archives Canada
Published Heritage 
Branch
395 Wellington Street 






395, rue Wellington 
Ottawa ON K1A 0N4 
Canada
Your file Votre reference 
ISBN: 0-612-96389-6 
Our file Notre reference 
ISBN: 0-612-96389-6
The author has granted a non­
exclusive license allowing the 
Library and Archives Canada to 
reproduce, loan, distribute or sell 
copies of this thesis in microform, 
paper or electronic formats.
The author retains ownership of the 
copyright in this thesis. Neither the 
thesis nor substantial extracts from it 
may be printed or otherwise 
reproduced without the author's 
permission.
L'auteur a accorde une licence non 
exclusive permettant a la 
Bibliotheque et Archives Canada de 
reproduire, preter, distribuer ou 
vendre des copies de cette these sous 
la forme de microfiche/film, de 
reproduction sur papier ou sur format 
electronique.
L'auteur conserve la propriete du 
droit d'auteur qui protege cette these. 
Ni la these ni des extraits substantiels 
de celle-ci ne doivent etre imprimes 
ou aturement reproduits sans son 
autorisation.
In compliance with the Canadian 
Privacy Act some supporting 
forms may have been removed 
from this thesis.
While these forms may be included 
in the document page count, 
their removal does not represent 
any loss of content from the 
thesis.
Conformement a la loi canadienne 
sur la protection de la vie privee, 
quelques formulaires secondaires 
ont ete enleves de cette these.
Bien que ces formulaires 
aient inclus dans la pagination, 
il n'y aura aucun contenu manquant.
Canada
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Abstract
Cellular survival and homeostasis is achieved due to the complex network of proteins 
present within cells to regulate responses to external stimuli. The phosphatidylinositol- 
3’-OH kinase (PI3’K) and the Wnt/Wg pathways, incorporate many important effector 
molecules and regulatory proteins to govern such cellular events as survival, apoptosis, 
cell-cell communication and fate determination. Protein kinase B (PKB) and glycogen 
synthase kinase-3 (GSK-3)/Shaggy are the main effector molecules in the PI3’K and 
Wnt/Wg pathways respectively, and rely on interactions with numerous regulatory 
proteins for initial phosphorylation or dephosphorylation, and subsequent activation. 
Integrin linked kinase (ILK) has been shown to act upstream of both PKB and GSK- 
3/Shaggy in mammalian systems, and regulates them in a PI3’K dependent manner and 
has been postulated as a PI3’K dependent protein kinase-2 (PDK-2) molecule. Studies 
with Drosophila ILK (DILK) further validate this idea. In the present study, it is shown 
that DILK is 59% similar to human ILK and is regulated in a PI3’K dependent manner 
in vivo. DILK is able to phosphorylate PKB in vitro and this occurs at serine-505 
residue, the Drosophila homologue to mammalian serine-473, in vivo. DILK was also 
shown to phosphorylate Shaggy, the GSK-3 homologue, in vitro. In addition, it was 
illustrated that insulin and wortmannin, PI3’K specific activator and inhibitor 
respectively, affect various genes at the nuclear level. Using microarray technology, 
insulin and wortmannin were shown to regulate the expression of 1151 genes, o f which 
two were chosen for further verification by RT-PCR. Dream was verified to be up- 
regulated by insulin and the functional significance of this effect still remains to be 
determined.
m
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Signal transduction pathways are very important cellular processes and are responsible 
for the survival and overall functioning of living cells. Complexity within cells is 
increased due to the numerous signaling pathways that cope with environmentally 
induced changes, and disruption o f these pathways can lead to adverse outcomes for the 
cell. Two distinct pathways, the phosphatidylinositol-3’-OH kinase (PI3’K) and the 
Wnt/Wg pathway, regulate cell survival, growth, apoptosis and fate determination.
There are many components of each pathway that are responsible for the transmission of 
the external signal to the interior of the cell, resulting in a cellular response that may 
include changes in cell physiology and morphology. These effector molecules must 
interact properly and efficiently to ensure the correct transmission of the desired signal. 
Integrin linked kinase (ILK) is an important mediator o f the PI3’K and Wnt/Wg 
pathways, and its complete characterization in Drosophila will aid in the understanding 
of how it functions. Many technologies are in place that allow for the characterization 
of cellular components and determination of cell function. Microarrays, a relatively new 
technology, have advanced gene studies to open a whole new world o f information 
previously unattainable with studies involving single gene analysis.
INTRODUCTION
The survival and fate o f a cell depends on the intricate functioning of numerous 
components within the cell that respond to external stimuli. The interplay between these
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
components regulates various cellular processes. Signal transduction pathways are 
responsible for the transduction of external stimuli to the interior o f the cell. Activation 
of these pathways can be initiated by binding of a ligand, such as growth factors, to their 
respective receptors, or by the interaction of the cell with the extracellular matrix (ECM). 
Subsequent events translocate effector molecules to the membrane leading to the 
phosphorylation or dephosphorylation of target proteins. The phosphatidylinositol-3’- 
OH kinase (PI3’K) and the Wnt/Wg pathways are two signal transduction pathways that 
regulate important cellular events such as survival, growth, apoptosis and fate 
determination. Attached to the integrin receptors in the plasma membrane, integrin 
linked kinase (ILK) has been shown to act upstream of both main effector molecules in 
these pathways.
The PI3’K Pathway
Regulation o f the PI3’K pathway is governed by numerous kinases and phosphatases.
The balance between the two maintains proper regulation of cellular processes. Protein 
kinase B (PKB), the main effector molecule of this pathway, is regulated by ILK. 
Initiation o f the pathway in response to stimuli, such as insulin, results in activation 
through the initial phosphorylation o f phosphatidylinositol 3-kinase (PI3’kinase), which 
is a known receptor proximal intracellular effector (Downward, 1997, and King et al., 
1997). PI3’kinases can be classified as class I, class II or class III, based on their 
substrate specificity in vitro. Studies with this kinase, including knock out and 
transgenic models in numerous organisms, have advanced our knowledge o f the 
mechanism of PI3 ’K signaling. This signal can be turned off by the tumour suppressor
2
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gene, phosphatase and tensin (PTEN), a phosphatidylinositol phosphatase, which is able 
to remove the phosphate from the 3’ position of the inositol ring in Ptdlns (3, 4, 5)P3 
(Maehama and Dixon, 1998, Myers et al., 1998, Stambolic et al., 1998). In addition, 
mutated platelet derived growth factor (PDGF) receptors that are unable to activate 
PD ’kinase are also unable to activate PKB (Burgering and Coffer, 1995, Franke et al., 
1995). Dominant negative P D ’kinase prevents the PDGF and insulin induced activation 
of PKB (Burgering and Coffer, 1995, Andjelkovic et al., 1996, Andjelkovic et al., 1997) 
and constitutively active forms of P D ’kinase are able to activate PKB (Didichenko et al., 
1996, Reif et al., 1997, Klippel et al., 1997). In Drosophila, it has been shown that flies 
possess three classes o f PI3’kinases, one which is homologous to mammalian p i 10, one 
which is homologous to mammalian Vps34p and a novel PD ’kinase (MacDougall et al., 
1995). Class 1A P D ’kinase, homologous to mammalian p i 10 and referred to as Dpi 10, 
is associated with a src-homology 2 (SH2) containing adapter p60, which is similar to 
the adaptor p85 in mammalian systems, but lacks the N-terminal src-homology 3 (SH3) 
domain and Philadelphia chromosome breakpoint cluster region gene product (BCR) 
domain (Weinkove et al., 1997). However, similar to mammalian systems, p60 
recognizes pYXXM (pY represents phosphotyrosine, M represents methionine and X 
can be any residue) motifs in receptor tyrosine kinases (RTKs) and associated substrates 
that also contain the pYXXM motif (Weinkove et al., 1997). Therefore, it is likely that 
Dpi 10 would act downstream of the Drosophila insulin receptor homologue, inr/dir 
(Fernandez et al., 1995, Ruan et al., 1995). This insulin receptor homologue contains a 
C-terminal extension with pYXXM motifs that have been shown to interact directly with 
P D ’kinase when artificially joined to the human insulin receptor (Yenush et al., 1996).
3
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Interestingly, there was weak loss of function in Drosophila due to mutations in the inr 
receptor that affected growth and reduced cell numbers (Chen et al., 1996). Studies with 
mammalian PI3’kinases have determined that class IP I3 ’kinases are heterodimers of 
approximately 200 kDa that phosphorylate phosphoinositide (Ptdlns), Ptdlns 4-P and 
Ptdlns (4 ,5)P2 in vitro, and preferentially phosphorylate PtdIns(4 ,5)P2 in vivo (Stephens 
et al., 1991, Hawkins et al., 1992 reviewed in Wymann and Pirola, 1998). Activation of 
this class o f PI3’kinases is due to several factors including extracellular signaling via 
membrane receptors that exhibit intrinsic protein tyrosine kinase activity, receptors that 
are coupled to src-like protein tyrosine kinases or receptors linked to G proteins. Of 
these three possible methods of activation, the activation of membrane receptors that 
exhibit intrinsic protein tyrosine kinase activity relates to the PI3’K signaling pathway. 
Class I P D ’kinase is inactive in quiescent cells, and upon activation by extracellular 
agonists such as insulin or platelet derived growth factor (PDGF), is translocated to the 
plasma membrane where it is activated, and subsequently increases the formation of 
secondary lipid products, such as Ptdlns (3,4 ,5)P3 (PIP3). This increase in secondary 
lipid products provides adequate resources for downstream molecular targets such as 
PKB/Akt. Protein kinase B is translocated to the membrane and activated upon 
interaction with phosphoinositides. Both Ptdlns (3, 4, 5)P3 and Ptdlns (3, 4)P2 can act as 
second messengers and recruit various proteins to the membrane (Toker and Cantley, 
(1997). PKB/Akt binds to the phosphoinositides PIP3 and PIP2 (3, 4) via its pleckstrin 
homology (PH) domain.
4
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PH domains are approximately 100 amino acids long and have been identified in many 
organisms, including Drosophila (Shaw, 1996, Rebecchi and Scarlata, 1998). When the 
PH domain o f PKB is mutated, it is unable to be activated by PIP2 through stimulation of 
the cell by PDGF (Franke et al., 1995, Franke et al., 1997), indicating that the PH 
domain is very important for PKB activation. It was shown that translocation o f PKB to 
the plasma membrane by insulin growth factor-1 (IGF-1) requires the PH domain, and 
could be negated by wortmannin, a PD ’kinase specific inhibitor (Andjelkovic et al.,
1997). Once PKB is targeted to the membrane, it is active (Andjelkovic et al., 1997).
The crystal structure for the PH domain of PKB bound to PIP3 was recently determined 
and reiterates equal affinity for binding o f PKB to PIP2 and PIP3 (Thomas et al., 2002).
Protein Kinase B (PKB)
Structure and Topography
Protein kinase B, also commonly referred to as Akt, is the major effector molecule of the 
PI3’K pathway and is activated by numerous growth and cell survival factors such as 
PDGF, insulin, cytokines and serum (reviewed in Galetic et al., 1999, Andjelkovic et al., 
2000, Chan et al., 1999, Datta et al., 1999, Kandel and Hay, 1999, Scheid and Woodgett, 
2001). PKB/Akt was originally identified from an oncogene, v-akt, found in a 
lymphoma characteristic o f rodent T-cells (Bellacosa et al., 1991). PKB is a 
serine/threonine protein kinase and belongs to the AGC or second messenger subfamily 
(Jones et al., 1991a; Jones et al., 1991b). The initial identification o f two ubiquitously 
expressed iso forms o f PKB, a  and P, introduced a new sub-family o f second messenger 
related kinases (Jones et al., 1991a and b, Coffer and Woodgett, 1991). A third isoform,
5
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PKBy, was later cloned from a rat cDNA library (Konishi et al., 1995). However, all 
PKB isoforms share a PH domain N-terminal to the catalytic domain followed by the C- 
terminal regulatory domain or hydrophobic motif (HM) (Haslam et al., 1993, Ingley and 
Hemmings, 1994). The HM regulatory domain provides a docking site for PI3’K 
dependent kinase-1 (PDK-1) (Balendran et al., 2000, Frodin et al., 2002, Biondi et al., 
2001) as well as allosteric regulation of catalytic activity (Frodin et al., 2002). Stability 
is ensued by association with hydrophobic and phosphate binding pockets in the kinase 
domain. This pocket is referred to as the PKC related kinase-2 (PRK2)-interacting 
fragment (PIF)-pocket due to its initial determination as the HM binding site of protein 
kinase PRK2 called PIF (Balendran et al., 1999). Together, these three domains form a 
phosphoprotein o f approximately 56 kDa that has been conserved throughout evolution 
from Caenorhabditis elegans through Drosophila to mammals. The consensus sequence 
for the PKB phosphorylation site was determined to be Arg-X-Arg-Y-Z-Ser/Thr-Hyd, 
where X can be any amino acid, Y and Z are small residues other than glycine and Hyd 
represents a bulky hydrophobic residue (Alessi et al., 1996b). This consensus sequence 
is found in a variety o f substrates allowing PKB to have many physiological functions 
and phosphorylate numerous downstream targets, including transcription factors.
PKB Functions
Protein kinase B was first identified as having a role in insulin signaling in Dr. Cohen’s 
lab, and was shown to inactivate GSK-3 (Cross et al., 1995). PKB negatively regulates 
serine-21 in GSK-3a and serine-9 in GSK-3P, in a PI3’K dependent manner. The 
inhibition of GSK-3 paralleled with the activation of glycogen synthase phosphatase
6
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accounts for the stimulation o f glycogen synthase resulting in glycogen synthesis in 
skeletal muscle and L6 myotubules (Cross et al., 1995).
Protein kinase B also plays a major role in cell survival and inhibition o f apoptosis. 
Upstream of PKB, PI3’kinase was initially implicated in the suppression of apoptosis 
(Yao and Cooper, 1995). It has been shown that PKB blocks apoptosis induced by 
various apoptotic stimuli, which may include i) removal of growth factors, ii) UV 
irradiation, iii) detachment o f cells from the ECM, iv) cell cycle arrest, or v) DNA 
damage (reviewed in Chan et al., 1999, Datta et al., 1999, Kandel and Hay, 1999). 
Subsequently, it was determined that PKB could also regulate cell survival.
Constitutively active PKB was found to promote cell survival in the absence of a 
stimulant and by inhibiting cell death machinery (Dudek et al., 1997). In eukaryotes, 
some members of the BCL-2 family of proteins regulate cell survival while others 
regulate cell death (Datta et al., 1999). BAD is a BCL-2 family protein that regulates 
cell death and is a direct target for PKB/Akt, which phosphorylates and inactivates this 
pro-apoptotic factor (Datta et al., 1997, del Peso et al., 1997). Other substrates that 
mediate cell death including the protease, caspase 9 (Cardone et al., 1998), the Forkhead 
family of transcription factors (Biggs et al., 1999, Brunet et al., 1999, Kops et al., 1999, 
Rena et al., 1999, Tang et al., 1999), and the NF-kB regulator kinase (Kane et al., 1999, 
Khwaja, 1999, Ozes et al., 1999, Romashkova and Makarov, 1999) are also direct 
substrates for PKB phosphorylation.
7
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Furthermore, the ability o f PKB to regulate cell growth is o f extreme importance with 
respect to tumourgenesis. The finding that the oncogene from the AKT8 retrovirus 
corresponds to the murine form of PKBa (c-Akt) fused to the viral gag protein was a 
dramatic discovery (Bellacosa et al., 1991). Fusion with the gag protein introduces an 
N-terminal myristic acid that allows PKB to translocate to the plasma membrane 
(Ahmed et al., 1993). It was later identified that this event was sufficient for the 
complete activation o f PKB by phosphorylation on both threonine and serine residues 
resulting in constitutive activation (Andjelkovic et al., 1997). Constitutively active 
forms of PKB help to explain the oncogenic potential of v-Akt, a chimera o f viral gag 
protein and PKB. The N-terminal myristic acid group of v-Akt alters the subcellular 
localization and consequently renders the kinase constitutively active (Andjelkovic et al., 
1997, Ahmed et al., 1993). Constitutive activation eliminates the normal course of 
events usually required for PKB activation.
The discovery that the catalytic subunit o f PI3 ’kinase has oncogenic potential has also 
reiterated the oncogenic nature of the PI3’K/PKB pathway (Chang et al., 1997), as well 
as the fact that PTEN, a major tumour suppressor gene, is an upstream negative 
regulator o f PKB (Maehama and Dixon, 1998, Myers et al., 1998, Stambolic et al.,
1998). Initially PTEN was not recognized as a negative regulator o f the PI3’K pathway 
and PKB. It was isolated as a tumour suppressor gene that was mutated in many forms 
o f cancer, which was thought to encode a dual specificity tyrosine phosphatase with 
preference for acid substrates (reviewed in Catley and Neel, 1999). This information 
allowed for the discovery that PTEN actually prefers phospholipids as substrates and
8
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functions to dephosphorylate the D3 position of PIP2 and PIP3 (Maehama and Dixon, 
1998, Myers et al., 1998), consequently acting as a negative regulator o f PKB. In an 
unstimulated cell, phosphorylated PKB levels are usually low. However, in PTEN- 
deficient tumour cell lines and immortalized fibroblasts and tumours collected from 
PTEN-deficient mice, PKB phosphorylation levels were high. In addition, P D ’kinase, 
PKB and cellular growth and transformation can be further connected due to the 
observation that Ras, a small GTP-binding protein that is mutated in many cancers, is 
itself an activator o f P D ’kinase (Rodriguez-Viciana et al., 1994). Studies in human 
tumours also revealed that PKBa is amplified in some gastric adenocarcinomas (Staal, 
1987) and ovarian carcinomas (Cheng et a l, 1992). Recently a novel protein, carboxyl 
terminal modulator protein (CTMP), has been identified and appears to act as a tumour 
suppressor, negatively regulating PKB by inhibiting its kinase activity (Maira et al., 
2001). Furthermore, TCL-1, a proto-oncogene involved in leukemia, has also been 
found to have a role in stimulating PKB activity (Pekarsky et al., 2000, Laine et al., 
2000). Therefore, it is evident that numerous PKB mutants are responsible for various 
types of cancer and that there are many important functions mediated by PKB in a PD ’K 
dependent manner. Thus regulation of PKB, such as that by ILK, has important 
implications due to the involvement of PKB in medical conditions such as diabetes and 
cancer, in addition to its role in cell survival, glucose uptake, protein synthesis and the 
regulation o f transcription factors and consequently, gene expression (reviewed in 
Galetic et al., 1999, Andjelkovic and Hemmings, 2000).
9
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PKB Regulation and Activation
Initially, by treating cells with phosphatase inhibitors, it became apparent that PKB 
activity is regulated by phosphorylation, and the kinase that was isolated from these cells 
was inactivated in vitro by protein phosphatase 2A (PP2A) (Andjelkovic et al., 1996). 
There is, however, a base level of PKB phosphorylation present in unstimulated cells, 
which increases upon stimulation with PDGF or pervanadate, a phosphatase inhibitor 
(Andjelkovic et al., 1996, Burgering and Coffer, 1995). PDGF stimulation augments 
serine phosphorylation (Burgering and Coffer, 1995) while pervanadate, a less specific 
activator and insulin mimic, is a more potent PKB activator and augments 
phosphorylation at both the serine and threonine residues (Andjelkovic et al., 1996).
Complete activation of PKB requires phosphorylation at many residues. Experiments 
with unstimulated human embryonic kidney (HEK) 293 cells initially mapped PKB 
phosphorylation sites, which showed constitutive phosphorylation on serine-124, located 
in the hinge region between the PH and catalytic domains, as well as threonine-450, 
which is found in the C-terminal area (Alessi et al., 1996b). The identification of the 
threonine-308 and serine-473 sites was not recognized until cells were stimulated. Upon 
stimulation with insulin or insulin growth factor-1 (IGF-1), the threonine-308/threonine- 
309 residues, located in the activation loop of the catalytic domain in PKB a, and the 
serine-473/serine-474, found in the C-terminal domain in PKB p, were phosphorylated 
(Alessi et al., 1996b). These two sites themselves were also found to be sensitive to 
PI3’K inhibitors (Alessi et al., 1996b, Meier et al., 1997), such as wortmannin (Arcaro 
and Wymann, 1993, Yano et al., 1993, Burgering and Coffer, 1995, Franke et al., 1995,
10
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Kohn et al., 1995) and LY294002 (Alessi et al., 1996). When either site was mutated to 
alanine, insulin stimulation of PKB was abolished, but mutation of both sites to aspartic 
acid, rendered PKB constitutively activated, and was resistant to wortmannin (Alessi et 
al., 1996b). PI3’K dependent activation of PKB includes membrane localization 
(Andjelkovic et al., 1997) followed by serine/threonine phosphorylation (Alessi et al., 
1996, Andejelkovic et al., 1996). While the PH domain of PKB/Akt promotes 
translocation to the membrane by binding to PIP3 (Franke et al., 1997 and Klippel et al., 
1997), phosphorylation of the serine and threonine residues is carried out by 
phosphoinositide-dependent kinases (PDKs) to completely activate PKB and allow for 














Figure 1.1. Schematic of ILK as a PDK-2 molecule in the regulation of PKB in 
the PI3’K pathway. PKB is completely activated by the phosphorylation of 
threonine-308 by PDK-1 in conjunction with phosphorylation of serine-473 by 
PDK-2.
11
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PI3’K Dependent Kinase-1 (PDK-1)
The existence of a PDK-1 molecule has been concretely identified and is responsible for 
the phosphorylation of threonine-308 on PKB (reviewed by Scheid and Woodgett, 2001). 
The threonine-308 site is located between the sub-domains VII and VIII o f the catalytic 
domain of PKBa, between the conserved regions, DFG-APE motifs (Hanks and Quinn, 
1991). This region was identified as the activation or T-loop through the identification 
of the crystal structures o f protein kinase A (PKA), cyclin-dependent kinase 2, mitogen 
activated protein kinase (MAPK), and CaMK-I (Johnson et al., 1996). Isolation of 
PDK-1 by two distinct research groups demonstrated it to be the first PKB upstream 
kinase by using its unique ability to phosphorylate PKB on threonine-308 in the 
presence o f 3’-phosphoinositides (Alessi et al., 1997a, Stokoe et al., 1997). This kinase 
was named as such because of its phospholipid requirement for phosphorylating PKB 
(Alessi et al., 1997b) and its activity is activated by the interaction of its PH domain with 
PIP3 and PIP2 (3,4) (Alessi et al., 1997a, Alessi et al., 1997b, Stokoe et al., 1997,
Stephens et al., 1998). PDK-1 has also been shown to regulate other second messenger- 
regulated kinases due to their similarities to phosphorylation sites in the activation loop 
of PKB. This idea was confirmed in studies that showed that PDK-1 phosphorylates a 
site in the catalytic domain of p70 S6K in vivo and in vitro when there was free access to 
the substrate achieved by hierarchical phosphorylation C-terminal to the catalytic 
domain (Pullen et al., 1998).
Two protein kinase C (PKC) isoforms have also been shown to be phosphorylated in 
vitro and in vivo by PDK-1 (Le Good et al., 1998) as well as threonine 197 on PKA,
12
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thereby activating the catalytic subunit in vitro (Cheng et al., 1998). Interestingly, 
serum-and glucocorticoid-regulated protein kinase (SGK) also appears to be another 
target for PDK-1. This kinase is transcriptionally regulated and is activated by insulin, 
IGF-1, peroxide and pervanadate in a PI3’K dependent manner, demonstrating 
similarities to PKB (Kobayashi and Cohen, 1999, Park et al., 1999). However, for 
complete activation o f PKB, phosphorylation must also occur at the serine-473 residue. 
This second phosphorylation event is one of great debate and has not yet been concretely 
determined. It has been speculated that the phosphorylation o f PKB on serine-473 can 
be achieved by autophosphorylation and does not require a second kinase. However, it 
has been shown that phosphorylation at the serine residue can in fact be carried out by a 
second, separate PDK molecule, termed PDK-2, for which ILK has been suggested.
PI3’K Dependent Kinase-2 (PDK-2)
PI3’K dependent kinase-1 (PDK-1) is responsible for the phosphorylation o f PKB at its 
threonine-308 residue. However, PKB must be regulated by both PDK-1 and PDK-2 
molecules, for complete activation. Integrin linked kinase (ILK) has been postulated as 
a possible PDK-2 molecule responsible for the phosphorylation o f PKB on serine-473. 
The serine-473 residue is homologous to the major rapamycin site o f p70 ribosomal S6 
kinase (p70 S6K), the threonine-389 site located C-terminal to the catalytic domain 
(Pearson et al., 1995). Similar sites are also present in PKC isoforms, p90 ribosomal S6 
kinase (p90 RSK), SGK and a nuclear serine/threonine protein kinase called Ndr (Park 
et al., 1999, Jensen et al., 1999, Millward et al., 1999). While there is evidence to show 
that ILK can function as a PDK-2 molecule, there is still speculation o f the mechanism 
of serine-473 phosphorylation in PKB. Autophosphorylation, one mechanism proposed
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for serine-473 phosphorylation, contradicts the PDK-2 theory (Toker and Newton, 2000). 
However, recent knockout studies that knock down ILK expression disprove this idea 
and show that ILK is required for serine-473 phosphorylation, thus supporting the role 
of ILK as a PDK-2 (Troussard et al., 2003). There are several other candidates 
suggested that can directly or indirectly phosphorylate this site. A biochemical approach 
where the C-terminal peptide of PKB was used as a substrate to purify kinase activity, 
identified and isolated MAPkinase-activated protein kinase 2 (MAPKAP-K2), a 
component o f the stress and cytokine-activated signaling pathway (Alessi et al., 1996). 
MAPKAP-K2 can phosphorylate serine-473 on PKB in vitro, but does not appear to do 
the same in vivo, likely due to the fact that it is activated by cellular stresses that do not 
activate PKB and inhibition of the pathway in which MAPKAP-K2 belongs does not 
inhibit PKB activation in vivo (Alessi et al., 1996).
Protein kinase C-C, (PKCQ, an atypical PKC, has also been shown to have the ability to 
phosphorylate a site homologous to PKB serine-473 in PKCa and PKC8 in the C- 
terminal V5 domain (Ziegler et al., 1999). Phosphorylation at this site is affected by 
PI3’K inhibition, which is plausible because PKC^ is also a downstream target of 
PI3’kinase, and has implications in insulin signaling (Mendez et al., 1997, Standaert et 
al., 1997). This may suggest a role for this kinase in the activation o f PKB. The two 
kinases were linked to each other when PKC(, was illustrated as a protein that interacts 
with the PH domain of PKB (Konishi et al., 1995). Recently it was discovered that 
numerous PKC inhibitors promoted PKB phosphorylation at serine-473, as well as 
increasing ILK activity (Wen et al., 2003). The ability of the PI3’K specific inhibitor
14
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wortmannin, and PDK specific inhibitor SB 203580, to block this phosphorylation leads 
to the conclusion that PKC negatively regulates PKB signaling (Wen et al., 2003).
There are still some observations that remain to be determined to fully understand the 
role ofPKCC in the regulation o f PKB. However, for this thesis, the ability of ILK to act 
as PDK-2 is the most relevant.
The overall activation and regulation of PKB has recently been reviewed and based on 
current findings, the model o f PKB activation has been altered slightly (reviewed in 
Scheid and Woodgett, 2003). Recent findings have determined that translocation of 
PKB to the membrane by 3’-phosphoinositide lipids promote serine 473- 
phosphorylation, which is necessary for subsequent PDK 1-mediated phosphorylation of 
threonine-308, resulting in full PKB activation (Scheid et al., 2002). The ability of ILK 
to phosphorylate serine-473 on PKB in mammalian systems has been studied 
extensively and findings will be paralleled in Drosophila studies in this thesis to further 
solidify ILK as a PDK-2 molecule in the PI3’K pathway.
The Wnt/Wingless Pathway
The main effector molecule of the Wnt/Wg pathway, GSK-3/Shaggy, is also regulated 
by ILK. Wingless is the Drosophila homologue to mammalian Wnt 1, and the pathway 
commonly incorporates both abbreviations. Wnt proteins are recognized as a major 
family o f  developmentally important signaling m olecules. Wnts are a family o f  secreted 
cysteine-rich, glycosylated protein ligands that bind membrane receptors and influence 
many cellular processes including cell-cell communication, differentiation, embryonic 
axis formation, migration, fate determination, development and growth in both
15
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vertebrates and invertebrates (Miller, 2002, Polakis 2000, Wodarz and Nusse, 1998, 
Yamaguchi, 2001, Smalley and Dale, 1999). The secreted Wnt proteins are 
evolutionarily conserved across species (Wodarz and Nusse, 1998), as well as the genes 
that are responsible for the transduction of the signals from the Wnt receptors to the 
nucleus (Cadigan and Nusse, 1997, Peifer and Polakis, 2000). In Drosophila, the product 
of the wingless (wg) gene is a secreted protein that is homologous to the vertebrate Wnt 
proteins (Klingensmith and Nusse, 1994). The complete mechanism of the Wnt/Wg 
signaling pathway has not yet been determined, but many of the components and 
downstream targets are known (Figure 1.2). Generally speaking, the Wnt proteins bind to 
the frizzled (fz) receptor to initiate transmission of the stimulus to the nucleus, where 
genes are activated that are regulated by T-cell factor/lymphoid enhancer factor 
(TCF/LEF) transcription factors (reviewed in Barker et al., 2000, Brantjes et al., 2002, 





Figure 1.2 -  Schematic of Wnt/Wg signaling. ELK has been shown to inhibit GSK-3 
and inhibit its acitivity in a PI3’k dependent manner
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The frizzled (fz)/Drosophila frizzled 2 (Dfz2) receptors are seven pass transmembrane 
protein receptors with cysteine-rich extracellular domains which function as the Wnt/Wg 
receptors (Bhanot et al., 1996). Activation of the frizzled receptor in turn activates 
dishevelled (Dvl/Dsh), which inactivates GSK-3/Shaggy, subsequently regulating P- 
catenin/armadillo (Arm). Dishevelled is a cytoplasmic phosphoprotein with a discs- 
large homology region (Klingensmith et al., 1994, Theisen et al., 1994, Yanagawa et al., 
1995) that is hyperphosphorylated in response to Wnt/Wg signals (Yanagawa et al.,
1995, Willert et al., 1997). Dishevelled has a dual role in the Wnt/Wg pathway. It 
serves to regulate GSK-3 levels as well as tissue polarity (reviewed in Ali et al., 2001). 
GSK-3/Shaggy phosphorylation leads to P-catenin/armadillo degradation through the 
ubiquitin-proteasome pathway (Aberle et al., 1997) and inhibition of GSK-3/Shaggy 
leads to higher cytoplasmic levels o f p-catenin/armadillo and nuclear translocation (Yost 
et al., 1996). The discovery that P-catenin was the mammalian homologue of armadillo 
(Peifer and Wieschaus, 1990, McCrea et al., 1991) implicated it as a possible signaling 
molecule, as armadillo was known to mediate the wingless pathway. An additional 
protein, axin, also has a role in this pathway. Axin/D-Axin are scaffold proteins that 
form a complex with GSK-3/Shaggy, p-catenin/armadillo and adenomatous polyposis 
coli (APC), a tumour suprressor gene (Behrens et al., 1998). In Drosophila, D -Axin 
over-expression destabilizes armadillo and it is found to be necessary for the proper 
functioning of GSK-3/Shaggy (Zeng et al., 1997) and the inhibition of P-catenin- 
mediated LEF-1 activation (Sakanaka et al., 1998). The mechanism by which the 
activation of Dsh inhibits GSK-3/Shaggy, thereby decreasing the phosphorylation of p- 
catenin/armadillo, is still not completely understood. In Drosophila cells it has been
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shown that Shaggy is inhibited by Wg, and that over-expression o f Dfz2 and Dsh 
reconstitutes Wg signaling determined by the inhibition o f Shaggy and subsequent 
armadillo accumulation (Ruel et al., 1999). It was also shown that Shaggy regulation 
controls armadillo levels by regulating D-Axin and armadillo phosphorylation (Ruel et 
al., 1999). Integrin linked kinase has been shown to interact directly with, and 
phosphorylate and inhibit GSK-3 (Delcommenne et al., 1998). However, the regulation 
of GSK-3 via ILK regulates glycogen sythesis and therefore does not act to regulate 
GSK-3 within the Wnt/Wg pathway. This regulation may occur directly by or indirectly 
through PKB. If independent, it may suggest two distinct pools of GSK-3/Shaggy.
Glycogen Synthase Kinase-3 (GSK-3)
The original identification o f glycogen synthase kinase 3 (GSK-3) illustrated its ability 
to phosphorylate, and consequently, inhibit glycogen synthase (Embi et al., 1980, Rylatt 
et al., 1980, Woodgett and Cohen, 1984). GSK-3 is a serine/threonine kinase and 
recognizes the sequence Ser/Thr-X-X-X-Ser/Thr-P where X can be any amino acid 
(often proline) and the second serine (S) is prephosphorylated (Fiol et al., 1990). There 
are two isoforms o f GSK-3: GSK-3a and GSK-3P (Woodgett, 1990). They differ by an 
N-terminal region rich in glycine in GSK-3a, which makes GSK-3 a  a larger protein with 
a mass o f 51 kDa, while GSK-3 p only has a mass o f 47 kDa. These two iso forms are 
structurally similar and are 98% homologous within their kinase domains (Woodgett 
1990); however, they are functionally distinct. Mice lacking the GSK-3P isoform 
resulted in an embryonic lethal phenotype for which the GSK-3a isoform could not 
rescue indicating that the phenotype was a result o f GSK-3 p alone (Hoeflich et al., 2000).
18
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Studies to determine the phenotype of mice lacking the alpha isoform have not yet been 
performed.
GSK-3 is the downstream effector molecule of the Wnt/Wg signaling pathway. Thus, 
the pathway can be interchangeably termed the canonical Wnt pathway or the Wnt/|3- 
catenin pathway (reviewed in Huelsken and Behrens, 2002, Polakis, 2000, Seidensticker 
and Behrens, 2000, Sharpe et al., 2001). GSK-3 has multiple phosphorylation sites that 
are required for its optimal performance. In resting unstimulated mammalian cells, 
GSK-3p is phosphorylated at Y216 and is constitutively active (Hughes et al., 1993). 
Therefore, it is difficult to identify the physiological significance o f this phosphorylation 
event. Bacterial expression of mammalian GSK-3 p illustrates evidence of 
autophosphorylation at this tyrosine residue, as well as at serine and threonine 
phosphorylation sites, which suggest that tyrosine phosphorylation may be autocatalytic 
(Wang et al., 1994). However, this was contradicted by immunoprecipitation o f GSK-3 
from mammalian cells that did not show the same behaviour (Hughes et al., 1993).
GSK-3 regulation is slightly unique. In unstimulated cells, it remains active and upon 
transmission of a signal, it is phosphorylated and inactivated. GSK-3 was the first 
physiological relevant substrate for PKB (Cross et al., 1995). Since then, GSK-3 itself 
has been identified as an important downstream substrate in numerous signaling 
pathways (reviewed in Frame and Cohen, 2001, Grimes and Jope, 2001, Woodgett, 
2001). Insulin stimulation of cells results in the inactivation o f GSK-3 in a PI3’K 
dependent manner. Activation of PKB through PI3’kinase results in phosphorylation of
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both GSK-3 iso forms: GSK-3 a  is phosphorylated on serine 21 and GSK-3 P is 
phosphorylated on serine 9, inhibiting GSK-3 (Cross et al., 1995). GSK-3 can also be 
phosphorylated and inactivated by numerous other stimuli including growth factors that 
stimulate p90RSIC through MAP kinases, a GSK-3 inactivating kinase or MAPKAP-K1 
(Brady et al., 1998, Saito et al., 1994), activators o f p70S6K such as amino acids 
(Armstrong et al., 2001, Krause et al., 2002, Terruzzi et al., 2002), activators of PKA 
(Fang et al., 2000, Li et al., 2000, Tanji et al., 2002), and activators of PKC (Ballou et al., 
2001, Fang et al., 2002). GSK-3/Shaggy is important to this work as it provides a 
platform on which to further elucidate the correct role of ILK in regulating both the 
PI3’K and Wnt/Wg pathways. Continual introduction of new molecular tools to carry 
out these studies will facilitate our understanding of cellular processes.
Microarray Technology
Studies of several cellular processes, including signaling pathways, have been further 
elucidated due to the advent o f microarray technology, which has greatly revolutionized 
gene expression studies and enabled numerous advances in science. Microarrays allow 
for the systematic study of gene expression across entire genomes o f most organisms. 
Prior to the invention of microarrays, Northern blot analysis or reverse transcription- 
polymerase chain reaction (RT-PCR), were employed to study the expression of a single 
gene. Microarray methodology allows for the determination o f gene expression data 
about hundreds or thousands of genes simultaneously. Microarray experiments are 
carried out relatively easily considering the vastness o f their potential. Creation of the 
microarray chip utilizes either oligonucleotides or amplified cDNA chosen from
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expressed sequence tag (EST) clone libraries, which is immobilized onto a glass surface 
using a robotic arrayer and referred to as "probes" (Figure 1.3). It was discovered that 
large scale sequencing o f cDNA would easily provide profiles o f ESTs and this concept 
was implemented in EST sequencing pioneered by Venter, and later widely adopted by 
others (Adams, 1993, Houlgatte, 1995, Khan et al., 1992). ESTs are short, single pass 
sequences derived by sequencing the ends of cDNA clones. They tend to be short (< 
500bp) and are o f lower quality than finished genomic sequences due to their single pass 
nature and provide abundant sequence information in a variety of species including 
Drosophila.
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Further studies to test and verify up/down 
regulated genes
Figure 3 -  Schematic representation o f  microarrav protocols resulting 
in data normalization. lilieiing and cltiMering io determine up down 
regulated genes
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In creating the actual microarray slide, ESTs are typically targeted to a density of
approximately 20,000 probes for an 8 cm2 slide. To determine the relative abundance of 
each of the spotted gene sequences in two distinct samples, total RNA samples are 
extracted from tissue or cells and labeled with fluorophores (Cyanine 3 and Cyanine 5) 
in a reverse-transcription (RT) reaction (Shalon, 1996). These labeled cDNAs, referred 
to as targets, are then mixed and hybridized onto the same chip. After hybridization the 
chip is washed, and scanned to create separate images for each fluorophor and the 
fluorescence intensity ratios are calculated for each element. These fluorescence 
measurements are then used to determine the ratio, and thus the relative abundance, of 
each gene is represented in the two samples. Each cDNA is present in a unique spot, 
therefore the relative abundance of each transcript is not a competition factor, and both 
rare and abundant transcripts can be assessed independently.
In addition to cDNA microarrays, oligonucleotide arrays are also used in microarray 
studies. These arrays are similar to cDNA arrays, except that the probe spotted onto the 
chip is a short synthetic oligonucleotide probe (Lockhart, 1996, Chee, 1996, Lipshutz, 
1999). These oligo-arrays are processed in the same manner as cDNA microarrays, 
except for the use o f less stringent washing conditions. Oligo-arrays can be more 
advantageous as they eliminate the need to acquire, store, maintain and amplify 
expensive EST clone sets. However, selection of oligonucleotide probes specific to a 
single gene or splice variant are a deciding factor and presents a unique challenge that 
large-scale nucleotide sequence analysis and bioinformatics tools can alleviate.
Extensive bioinformatics tools are required following a microarray experiment to
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analysis the results as depicted in figure 1.3. Microarrays have provided a valuable tool 
in which to study downstream effects on genes and illustrate how cells change in 
response to various stimuli. In the present study, this ability o f microarrays will be 
exploited to determine the effects of insulin and wortmannin on Drosophila genes.
Project Objectives
Drosophila ILK (DILK) was previously isolated by our lab and partially characterized. 
The main objective o f this thesis was to further characterize Drosophila ILK. 
Drosophila melanogaster Schnieder (S2) cell lines were utilized to carry out this 
research. They are ideal for the study of components of signaling pathways as they are 
relatively easily manipulated and have certain characteristics eliminating the effects of 
other pathways that may interfere with the desired results. In vivo phosphorylation 
assays, in vitro kinase assays and phospho-western blot analysis were carried out to 
further elucidate functions of D-ILK. These studies will add information to growing 
evidence for D-ILK as a PDK-2 molecule, responsible for the phosphorylation o f PKB 
on the conserved serine residue. Microarray experiments will be employed to identify 
genes that may be regulated by insulin and wortmannin, in a PI3’K dependent manner. 
Further studies including RT-PCR to validate the microarray regulation of selected 
genes and to identify possible new targets that may be regulated in a PI3’K dependent 
manner up or downstream o f  Drosophila ILK w ill be carried out.
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CHAPTER Two
Biochemical Characterization of Drosophila Integrin Linked Kinase (ILK) 
Chapter Summary
There has been extensive research on mammalian integrin linked kinase (ILK) and its 
role in signaling pathways. However, the role of Drosophila ILK still remains only 
partially understood. Characterization of this protein will aid in the understanding of its 
role in the PI3’K and Wnt/Wg pathways. In mammalian systems, ILK has been 
speculated to act as a PI3’K dependent kinase-2 (PDK-2) molecule, phosphorylating 
PKB on its serine-473 residue. However, this view is controversial and it is therefore 
necessary to examine the role of evolutionarily conserved ILK in other model systems. 
Complete activation of PKB occurs in conjunction with another important mediator of 
the PI3’K pathway, PI3’K dependent kinase-1 (PDK-1). Integrin linked kinase has also 
been shown to play a role in the Wnt/Wg pathway by phosphorylating GSK-3. The 
ability of ILK to regulate both PKB and GSK-3 provides an interesting link for crosstalk 
between the two pathways. Characterization of Drosophila ILK and determination of 
how it interacts with, and regulates downstream effector molecules, will provide 
pertinent information needed for the complete understanding of cellular signaling in 
Drosophila through the PKB/ILK pathway, and illustrate its ability to act as a PDK-2 
molecule.
INTRODUCTION
The PI3’K pathway is completely activated when two important regulatory molecules, 
PDK-1 and PDK-2, phosphorylate threonine and serine residues on PKB respectively.
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Integrin linked kinase has been implicated as a possible PDK-2 molecule responsible for 
the phosphorylation o f the serine 473 residue on PKB. Human ILK was first identified 
from a yeast two-hybrid screen of a human cDNA library, as a serine/threonine protein 
kinase, which interacts with (31, 02, 03 integrins (Hannigan et al., 1996). Integrin linked 
kinase is thus named due to its interactions with integrins. Integrins are heterodimeric 
cell surface adhesion receptors responsible for cellular adhesion and migration through a 
physical link between the extracellular matrix (ECM) and the cytoskeleton (Hynes, 
1992), as well as activation of intracellular signaling processes (Clark and Brugge, 1995, 
Attwell et al., 2000). The murine form of ILK was later identified (Li et al., 1997) and 
the protein sequence was found to be 99% homologous to human ILK, thus illustrating 
evolutionary conservation between species (Hannigan et al., 1996, Li et al., 1997). 
Mouse and human ILK both contain 452 amino acids, resulting in a total molecular mass 
of 59 kDa. The ILK protein sequence contains three structurally distinct domains. At 
the N-terminus there are four ankyrin (ANK) repeats whose structure still remains to be 
determined. It has been speculated that these repeats likely contain an antiparallel 0- 
sheet and a-helices that lie perpendicular to the 0-sheet (Sedgwick and Smerdon, 1999). 
Studies have shown that these repeats can interact with a LIM domain protein, PINCH 
(Tu et al., 1999) and regulate the localization of ILK in focal adhesion plaques (Li et al., 
1999). Situated C-terminal to the ankyrin repeats is the pleckstrin homology (PH) 
domain. This domain is responsible for binding to the secondary lipid products of 
PI3’kinase. Lastly, the C-terminal catalytic kinase domain exhibits sequence homology 
to other protein kinase domains, but lack several sequences that are observed in other 
typical catalytic domains (Hannigan et al., 1996).
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The identification of ILK resulted in subsequent experiments to determine its 
downstream targets. Integrin linked kinase from human embryonic kidney cells was 
stimulated by fibronectin and insulin in vivo in a PI3’K dependent manner, and by 3- 
phosphoinositides in vitro, in addition to direct phosphorylation of PKB on serine-473 
in vitro, and inhibition of phosphorylation of PKB on serine-473 in vivo by ILK kinase 
deficient (E359K mutant) (Delcommenne et al., 1998). It was also determined that ILK 
directly phosphorylates GSK-3 (Delcommenne et al., 1998). Furthermore, ILK can 
down-regulate E-cadherin expression, thus promoting the nuclear translocation and 
activation o f P-catenin (Wu et al., 1998, Novak et al., 1998) and studies over-expressing 
ILK in epithelial cells results in anchorage independent cell survival and cell cycle 
progression (Radeva et al., 1997). A few years later, it was shown that over-expression 
of ILK in epithelial cells results in tumourgenesis in nude mice (Wu et al., 1998). The 
anti-apoptotic role and oncogenic nature of ILK resembles that o f PKB and helps to 
solidify its role as a putative serine-473 kinase. It has been shown that ILK and 
PKB/Akt are constitutively activated in human prostate carcinoma cells that lack PTEN 
(Persad et al., 2000). Transfection of kinase-deficient dominant-negative ILK inhibits 
serum and anchorage-independent PKB/Akt serine-473 phosphorylation therefore, 
inhibiting PKB activity causing Gi cell cycle arrest and apoptosis (Persad et al., 2000).
Recently there has been growing evidence to support ILK as a PDK-2 molecule.
Initially it was reported that PDK-1 was responsible for ser-473 phosphorylation 
(Balendran et al., 1999). However, this site was inducibly phosphorylated in PDK-1 
knock-outs, indicating existence o f a second, PI3’K dependent ser-473 kinase (Williams
26
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et al., 2000). ILK has been shown to act as this serine-473 kinase, as it phosphorylates 
PKB/Akt on this residue in vitro, and not on threonine-308 (Nicholson and Anderson, 
2002, Delcommenne et al., 1998, Wu and Dedhar, 2001, Lynch et al., 1999, Persad et al., 
2001, Cruet-Hennequart et al., 2003). To further this notion, activation of PKB/Akt by 
both growth factor and ECM stimulation is inhibited by kinase-deficient (S343A) 
dominant negative ILK (Nicholson and Anderson, 2002, Lynch et al., 1999, Persad et al., 
2001). A small-molecule ILK inhibitor was also found to inhibit serum-independent 
PKB/Akt serine-473 phosphorylation (Persad et al., 2000) thus improving previous 
inhibition studies with ILK that utilized P D ’kinase inhibitors, which are less specific to 
ILK. To definitively illustrate ILK’s ability to act as a serine-473 kinase, ILK knockouts 
were used. Small interference RNA (siRNA) and the Cre-Lox system were used to 
knockout ILK in HEK-293 cells and mice respectively (Troussard et al., 2003). These 
knockouts resulted in the inhibition o f PKB activity by suppressing serine-473 
phosphorylation without affecting threonine-308 phosphorylation (Troussad et al., 2003). 
This loss o f serine-473 was rescued by transfection of kinase-active ILK, but not by 
kinase-deficient ILK (S343A mutant), in addition to inhibiting GSK-3 phosphorylation 
and decreasing the expression of cyclin Di (Troussard et al., 2003).
The above studies collectively provide evidence that ILK does indeed exhibit the ability 
to act as a PDK-2 molecule in mammalian systems. Our studies with Drosophila are 
possible due to the ease o f manipulation of this system to effectively deduce known 
downstream targets of DILK and determine the mechanism of action. The PI3’K and 
Wnt/ Wg pathways are both conserved throughout evolution and are both required in
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Drosophila. The study of the PI3’K pathway was enhanced by the isolation and 
characterization o f the Drosophila PKB/Akt mutant, Daktl, and the subsequent genetic 
analysis o f Drosophila PKB/Akt (Staveley et al., 1998). It was found that Daktl 
exhibited ectopic apoptosis during embryogenesis, as was indicated by induction of 
membrane blebbing, fragmentation of DNA and membrane blebbing (Staveley et al., 
1998). Apoptosis as a result of loss of Daktl function was rescued by caspase 
suppression in a distinct manner than with previously identified reaper/grim/hid 
functions (Staveley et al., 1998), illustrating that D aktl is in fact a cell survival gene in 
Drosophila, as is consistent with results from cell protection studies in mammalian 
systems. This work with Drosophila PKB provides a platform for work on upstream 
effector molecules, like Z)ILK, and downstream targets, to elucidate how each functions 
in the pathways and regulates cellular functions. In this chapter, we show that DILK can 
indeed act as a PDK-2 molecule, and phosphorylates PKB as well as Shaggy/GSK-3.
MATERIALS AND METHODS
Cell Culture and Transient Transfections
Drosophila Schneider 2 (S2) cells (ATCC) were grown in Schnieder Insect media 
(Sigma) containing 10% Fetal Bovine Serum (FBS) (Gibco) and 5% 
Penicillin/Streptomycin (P/S) (Gibco) and incubated at 22°C according to Ruel et al., 
1999. DILK-V5 wild-type (wt) and DILK-V5 kinase deficient (kd) (E356K mutant) 
were sub-cloned into pAC5.1 A expression vector and transiently transfected into S2 
cells. Thirty- six pis o f C aC f was added to 10 pg of DNA and brought up to 300 pi 
with double-distilled filtered water. This mixture was then added drop by drop, while
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vortexing, to 300 (0,1 o f 2x HBS transfection buffer (Ruel et al, 1999). After incubation 
at room temperature for 45 minutes, the transfection mixture was added carefully to the 
sides of plated S2 cells (3 mL per well) and incubated overnight at 22°C. The next day, 
the media was changed and the cells were incubated at 22°C for another night. The cells 
were induced with 60 pg/pl insulin, 0.1 mM pervanadate or 200 nM wortmannin, and 
subsequently lysed in 600 pi o f gentle soft buffer (lOmM NaCl, 20mM PIPES, 0.5% 
NP40, 0.05% 2-mercaptoethanol, 5mM EDTA, 100 pM, 5 pg/ml Leupeptin, 5 pg/ml 
Aprotinin, 50 mM NaF, 1 mM Benzamidine).
Sequence Analysis
ClustalW was used to generate amino acid sequence alignment o f Drosophila ILK with 
the known sequence o f human ILK.
Immunoprecipitation and Kinase Assays
Drosophila S2 cells were treated with the PI3’K specific inhibitor, wortmannin, at a 
final concentration o f 200 nM for 10 mins prior to treatment with insulin (60 pg/pl) and 
pervanadate (0.1 mM), which were added to the cells for 15 mins. Cells were then lysed 
in gentle soft buffer (lOmM NaCl, 20mM PIPES, 0.5% NP40, 0.05% 2-mercaptoethanol, 
5mM EDTA, 100 pM, 5 pg/ml Leupeptin, 5 pg/ml Aprotinin, 50 mM NaF, 1 mM 
Benzamidine) and total protein extract was collected following centrifugation. 
Endogenous DILK was immunoprecipitated from the lysate using 30 pi of polyclonal D- 
ILK antibody in solution with 20 pi of Protein G Sepharose beads (Amersham 
Biosciences) incubated overnight, with continual shaking, in the cold room. The agarose
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beads were collected by centrifugation and washed three times with 1 mL of gentle soft 
buffer. Fractionated DILK was also collected via FPLC. Briefly, DILK-V 5 wt 
transfected S2 cells were lysed in hypotonic gentle soft buffer and the protein extract 
was collected and fractionated by FPLC with various column types. PKB and Shaggy 
kinase assays were then performed using radio-labelled 32P Gamma ATP (Amersham 
Pharmacia) as initially described by Jin et al., 2001. A master mix o f 4.75 pi of cold 
ImM ATP, 10 pi o f 5x kinase buffer (50mM MgC12, 250mM Tris-Cl pH 7.5, 5 mM 
EGTA pH 7.5), 1 pi of substrate (PKB-GST or immunoprecipitated Shaggy), and 0.5 pi 
of P ATP Gamma (Amersham Pharmacia), brought up to 50 pi with double distilled 
water was made. Thirty pis of the master mix was then added to 20 pi o f DILK and 
incubated at 30°C for 30 minutes. Fifty pis of 2x SDS sample buffer was added to the 
reaction and heated at 95°C for 5 minutes to denature the proteins. The samples were 
electrophoresed on a 12% SDS-PAGE protein gel. The gel was then dried for 1 hour at 
80°C on a gel dryer (BioRad) under vacuum and exposed overnight.
Immunoblot
Drosophila S2 cell lysate was collected for western blot analysis as described above. 
Cell homogenates were electrophoresed on a 12% SDS-polyacrylamide gel and 
electrophorectically transferred using a Hoefer SemiPhor semi-dry transfer unit 
(Amersham Pharmacia) to PVDF membrane (Pall). After transfer, the blot was placed 
in 4% Blotto for 2 hours at room temperature (4% Skim milk, 10X PBS, 25% Tween) to 
block non-specific binding sites on the membrane. Following overnight incubation at 
4°C with primary antibodies at a 1 TOO dilution (polyclonal DILK and polyclonal Sgg) 
and 1:1000 dilution (polyclonal phospho-serine 473 Akt and monoclonal V5) in 2%
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blotto (2% Skim milk, lOx PBS, 25% Tween), the membrane was then washed with 2% 
Blotto 6 times for 5 minutes each time. For detection of polyclonal DILK, PKB 
phospho-serine 473, Shaggy and monoclonal V5, the membrane was incubated with 
anti-rabbit or anti-mouse horseradish peroxidase secondary antibodies (Amersham 
Pharmacia) and washed again with 2% blotto 6 times for 5 minutes each time. 
Visualization was by chemiluminescence (Perkin Elmer) and size was determined by 
comparison with high molecular weight rainbow marker (Amersham Biosciences).
In vivo Labelling
Drosophila S2 cells were grown to an approximate density of 5x106 cells/ml and in vivo 
labeling was carried out as described by Ruel et al., 1999. One mL of master mix {1 mL
3 9Schneider’s Insect media (Sigma), 0.75 pi o f P orthophosphate (Amersham Pharmacia) 
per sample} was added to the cells after the removal o f the existing media and incubated 
overnight at room temperature in phosphate free media. The next day, insulin (60 pg/pl) 
was added to the cells and incubated for 15 minutes. The media was aspirated off and 
the cells were centrifuged for 10 minutes at 15000g at room temperature before the 
addition of 600 pi o f gentle soft buffer. The supernatant was collected and DILK was 
immunoprecipitated overnight using 30 pi of DILK antibody/sample. The protein was 
electrophoresed on a 12% SDS-PAGE gel and visualized by autoradiography.
PKB-GST Fusion Protein and Purification
PKB-GST was purified as outlined in the Promega GST Fusion Protein protocol. PKB 
was previously sub-cloned into the pGEX 4T-1 vector (Amersham Pharmacia) and
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subsequently transformed into E. coli BL-21 cells and grown in 100 mL YT broth 
(0.01% tryptone, 0.005% yeast, 0.005% NaCl) overnight. The next day the samples 
were diluted to 1 L with fresh YT broth and grown at 37°C (shaker) until they reached 
an OD of 0.5. Four millilitres of Isopropyl-beta-D-thiogalactopyranoside (IPTG) 
(Invitrogen) (final concentration 0.1 M) was added to the broth mixture. Induction was 
performed at 37°C in covered flasks for 0 hrs (no IPTG) and 4 hrs. The cells were 
centrifuged immediately at 10 OOOg for 10 minutes at room temperature. The pellet was 
dissolved in 10 mL of lOx PBST (phosphate buffered saline/tween). Sonication was 
performed in the Sonic Dismembrator 60 (Fisher Scientific) 3 times for 15 seconds at 
level 3. Samples were then centrifuged at 15 OOOg for 20 minutes and the supernatant 
was collected. Five hundred pis of slurry {250 pi o f glutathione beads immobilized on 
cross-linked 4% beaded agarose (Sigma)} was added to the supernatant and nutated 
overnight at 4°C. The samples were then centrifuged at lOOOg for 30 seconds to pellet 
the glutathione beads. The supernatant was removed and the beads were washed with 10 
mL of lx  PBST plus inhibitors (15mM NaCl, 16mM Na2H P04, 4mM NaH2P 0 4, 0.1% 
Triton xlOO, 50mM NaF) and incubated with gentle shaking for 10 minutes, repeated 
three times. The remaining supernatant was removed and 10 mL elution buffer (20mM 
reduced glutathione, lOOmM Tris pH 8.0, 150mM NaCl, 0.1% Triton xlOO pH 7.0) was 
added to the samples, and nutated for 4 hours at 4°C. The sample was then centrifuged 
at lOOOg for 1 minute to pellet the beads. The supernatant containing the protein was 
collected and dialyzed. Dialysis tubing (Sigma) was saturated in 1 L o f dialysis buffer 
(25 mM Tris pH 7.4, 1 mM EDTA, 0.2 mM EGTA,1 mM DTT, 50% glycerol) before 
the sample was added. The protein was added to the tubing, and it was clamped and
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incubated on a stirrer overnight at 4°C. The dialysis buffer was changed the next 
morning and incubated for 3 hours. The protein was collected and lx  the volume of 
glycerol was added before storage at -20°C.
Image Quantification
Images were quantified by Adobe Photoshop and represented as the difference in mean 
intensities.
RESULTS 
Drosophila ILK Shows High Sequence Homology to Human ILK
Integrin linked kinase (ILK) has been shown to be highly conserved throughout 
evolution. The sequence of DILK encodes a conceptual reading frame that translates to 
a protein o f 448 amino acids (Figure 2.1). Alignment o f human and Drosophila ILK 
showed a high degree o f homology (Figure 2.1). Human ILK and Drosophila ILK share 
59% similarity at the amino acid level (GenBank accession numbers AAH01554 and 
AAF28365 respectively). The DILK sequence also encodes N-terminal ankyrin repeats, 
a central PH domain and a C-terminal kinase catalytic domain, as is found in human ILK. 
Drosophila ILK contains 4 ankyrin repeats, and all 4 ankyrin domains generally exhibit 
the conserved consensus sequence, with only 10 amino acid differences across all 4 
repeats. The PH domain of Drosophila ILK is also conserved, exhibiting only 3 amino 
acid differences within the conserved residues important for binding o f the 
phosphatidylinositol lipid products. The DILK kinase catalytic domain is structurally 
similar to that o f human ILK and contains the important conserved glutamic acid (E) at 
position 356 (359 in hILK) which when mutated, renders the kinase inactive.
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Figure 2.1. Amino acid sequence alignment of ILK homologues. The deduced amino 
acid sequence of Drosophila ILK (GenBank accession number AAF28365) was 
compared to human ILK sequence (GenBank accession number AAH01554). Identities 
are shown as asterisks, while dashes represent gaps introduced to maximize sequence 
alignment. The ankyrin, PH and kinase catalytic domains are conserved between the 
species. The four ankyrin repeats (consensus sequence -G-TPLH-AA—GH—V—LL-- 
GA—N) are in bold and stretch from residues 34-130. The PH domain (consensus
sequence GWLXK— GXXXK WKXRW) is italicized and stretches from residues
179-211. Amino acids underlined within the PH domain indicate residues important for 
the binding of phosphatidylinositol lipid products. The kinase domain (bolded) begins at 
residue 186 and extends to the end o f the protein. The A indicates the position in the 
kinase domain that when converted from E to K renders the kinase inactive. The 2 
protein sequences are 59% similar and the amino acid differences are shown in red.
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MDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAWEMLIMRGARI 6 0 
MEDIFHWCREGNSIQVRLWLDETEHDNNLGDDHGFSPLHWVAKEGHAKLVETLLQRGSRV 60 
*  * * *  * * * * *  * * * * * *  * *  *  *  * * * * * * * * * * *  * *  * *  *  * *  *
N  G- -TPLH-AA- -GH V- -LL- -GA- -N G-TPLH-AA- -GH- -V LL
NVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLV 12 0 
NATNMGDDIPLHLAAAHGHRDWQMLIKERSDVNAVNEHGNTPLHYACFWGYDMICEDLL 12 0
*  *  * * *  * * * * * *  * * * * *  * *  *  *  * * * * * * * *  * * * * * * * * *  *  * * *
- - GA-----N G
ANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNRIPYKDTFWKGTTRTRPRNG 18 0 
NAGAQVGIANKDGHTPLEKAKPSLAKRLQDLVEKSGREVKVISFKEQSWQG-LKTRSRDA 17 9 
* *  *  *  * *  *  *  * * *  *  *  * * *  *  *  * *  * *  *
PH D om ain
TLNK— G ID FK----------------- WKGRW Kinase Catalytic Domain
TLJYKHSGIDFKQLNFLTKLNENHSGELWfCGRWQGNDIWKVLKVRDWSTRKSRDFNEECP 240 
rLSRFKGJSAfGDLDLHTKLSVTPSGETWRGRWQKNDWAKILAVRQCTPRISRDFNEEFP 23 9 
** ** * *** *** * **** * * * * * ** * ******* ★
RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFWDQSQAVKFALD 3 00 
KLRIFSHPNILPIIGACNSP--PNLVTISQFMPRLSLFSLLHGATGVWDTSQAVSFALD 297 
* * * * * * * *  * *  * * *  * *  *  *  * *  * *  * *  *  * * *  * * * *  * * * *
A
MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQCPGRMYAPAWVAPEA 3 6 0 
VARGMAFLHSLERIIPTYHLNSHHVMIDDDLTARINMGDAKFSFQEKGRIYQPAWMSPET 3 57 
******** ** ** *** **** * **** *  *  * * * * *  * *  *  * * *  * *
LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 42 0 
LQRKQADRNWEACDMWSFAILIWELTTREVPFAEWSPMECGNEIALEGLRVKIPPGTSTH 417
* *  *  *  *  * * * * * *  *  * * *  * * * * * * *  *  * *  *  * * * * * *  * * * *  *  *
VCKLMKICMNEDPAKRPKFDMIVPILEKMQDK 452 
MAKLISICMNEDPGKRPKLDMWPILEKMRR- 448 
** ******* * * * *  * *  * * * * * * *
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In vivo Phosphorylation of DILK
In order to analyze the effects o f insulin on the phosphorylation of DILK, we performed 
in vivo labelling using S2 cells. Radiolabelled 32P orthophosphate was added to 
Drosophila S2 cells and after overnight incubation and insulin treatment, the lysate was 
collected. DILK was immunoprecipitated, using polyclonal DILK antibody and its 
phosphorylation in vivo was detected by autoradiography (Figure 2.2). In untreated cells, 
the phosphorylation of DILK was 4.3 times greater than the control. The control did not 
contain immunoprecipitated DILK and therefore the slight expression o f DILK can be 
attributed to endogenous activity. After treatment with insulin, DILK phosphorylation 
was 16.3 times greater than the control and 3.8 times greater than the non-insulin treated 
cells.
PI3’K Dependent Phosphorylation of PKB by DILK in vitro
To correlate the insulin induced phosphorylation o f DILK with its ability to 
phosphorylate downstream targets in vitro, we performed an in vitro kinase assay. PKB- 
GST, isolated and purified from BL-21 cells, was used as a substrate for 
immunoprecipitated DILK from Drosophila S2 cells. The in vitro kinase assay used 
radiolabelled 32P and was incubated for 30 minutes at 30°C to illustrate the ability of 
Drosophila ILK to phosphorylate substrate PKB-GST (Figure 2.3). Insulin, a PI3’K 
activator, phosphorylation of PKB-GST was 17 times greater than the control. 
Pervanadate, a phosphatase inhibitor and a less potent stimulant o f DILK activity, 
phosphorylation o f PKB-GST was 1.5 times less than that exhibited by insulin. The 
phosphorylation o f PKB-GST was inhibited by wortmannin, a PI3’K specific inhibitor,
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Figure 2.2. In vivo phosphorylation o f endogenous DILK. In vivo labelling with 32P 
orthophosphate was performed in Drosophila S2 cells, followed by treatment with 
insulin for 15 mins, and subsequent lysis in gentle soft buffer. DILK was 
immunoprecipitated with DILK polyclonal antibody. The control (lane 1) did not 
contain immunoprecipitated DILK. Immunoprecipitated DILK (lane 2) was untreated 
and lane 3 was treated with insulin. A Western blot using the DILK antibody illustrated 
the presence of endogenous ILK.
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Figure 2.3. PI3’K dependent phosphorylation of PKB by DILK in vitro. Drosophila S2 
cells were treated with insulin, pervanadate and wortmannin and DILK was isolated with 
a polyclonal DILK antibody. The control lane shows the untreated sample (lane 1). 
Insulin alone was added to the cells for 15 minutes (lane 2), pervanadate for 15 minutes 
(lane 3) and wortmannin for 15 minutes (lane 4). In lanes 5 and 6 wortmannin was 
added to the cells 10 minutes prior to treatment with insulin and pervanadate, which was 
then incubated for 15 minutes. A PKB kinase assay was then performed using radio­
labelled 32P. A western blot using anti-D-ILK antibody illustrated the relatively equal 
levels of endogenous D-ILK.
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resulting in 100 times less PKB phosphorylation than pervandate. When administered 
prior to treatment with either insulin or pervanadate, its inhibitory affects were 
essentially irreversible. Wortmannin plus insulin showed 1.1 times greater 
phosphorylation o f PKB than wortmannin alone, and wortmannin plus pervanadate 
showed 1.6 times less phosphorylation of PKB than wortmannin plus insulin. The 
control blot shows that DILK was present in relatively equal amounts in each treatment 
group.
Drosophila ILK Phosphorylates PKB at serine 505 in vivo in a PI3’K Dependent 
Manner
In mammalian systems, it has been shown that ILK phosphorylates PKB at serine-473. 
However, no study has shown the in vivo phosphorylation of this residue by DILK. To 
determine this, Drosophila S2 cells were transiently transfected with DILK-V5 wt or 
DILK-V5 kd (E356K mutant) and treatment with insulin (60 pg/pl), pervanadate (0.1 
mM) and wortmannin (200 nM). A PKB phospho-serine 473 western blot determined 
phosphorylation at this residue (Figure 2.4). Insulin increased the phosphorylation of 
PKB/Akt at serine-505 (homologue to mammalian serine-473) in vivo (Figure 2.4a). 
Cells transfected with DILK-V5 wt in the presence of insulin showed 2.3 times the 
phosphorylation at PKB serine-505, as compared to the non-transfected cells in the 
presence o f insulin and 2.3 times the phosphorylation o f unstimulated transfected cells. 
Kinase deficient DILK stimulated with insulin demonstrated 1.3 times less 
phosphorylation than DILK-V5 wt insulin treated cells. Similarly, cells treated with 
pervanadate, a phosphatase inhibitor, showed 1.9 times more phosphorylation o f serine- 
505 in DILK-V5 wt transfected cells than in DILK kinase deficient transfected cells
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Figure 2.4. a) Insulin increases the phosphorylation of PKB/Akt at serine-505 in vivo. 
Drosophila S2 cells were transiently transfected with D-ILK-V5 wt or D-ILK-V5 kd 
(E356K mutant) in the absence or presence o f insulin (60 pg/pl), a P B ’-K activator, for 
15 mins. Total protein extract was collected 48 h after treatment and subjected to 
phospho-westem blot analysis using anti-pS473-Akt antibody. The blot was reprobed 
with anti-V5 antibody to illustrate transfection efficiency, b) Pervanadate increases the 
phosphorylation of PKB/Akt in Drosophila S2 cells in vivo. Drosophila S2 cells were 
transiently transfected with V5-tagged D-ILK  wild-type (wt) or D-ILK kd (E356K 
mutant). The transfected cells were treated with 0.1 mM pervanadate (a phosphatase 
inhibitor) for 15 mins. Cells were lysed in gentle soft buffer and total protein was 
extracted and subjected to phospho-westem blot analysis using anti-pS473-Akt antibody. 
Transfection efficiency was estimated by reprobing the blot with anti-V5 antibody, c) 
PI3’-K inhibitor wortmannin blocks the phosphorylation of PKB/Akt in Drosophila S2 
Cells in vivo. Drosophila S2 cells were transiently transfected with D-ILK-V5 wt in the 
absence or presence of pervanadate (0.1 mM), a phosphatase inhibitor, or wortmannin 
(200 nM), a PI3-K inhibitor, or a combination of both. Total protein was extracted after 
48 h and subjected to phospho-westem blot analysis. Reprobing of the blot with anti-V5 
antibody illustrated the transfection efficiency.
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(Figure 2.4b). Wortmannin, a PI3’K specific inhibitor, negated PKB serine-505 
phosphorylation when applied alone, and cells treated with wortmannin prior to 
treatment with pervanadate exhibited 1.6 times less phosphorylation at this residue 
(Figure 2.4c). Phosphorylation in the presence o f pervandate was 2.0 times greater than 
DILK-V5 wt transfected cells not treated with pervanadate. The transfection levels of 
DILK-V5 are illustrated as a control in each experiment and shows relatively equal 
expression across the samples.
Phosphorylation of Shaggy by DILK in vitro
ILK also functions to regulate GSK-3 in mammalian systems. However, the ability of 
Drosophila ILK to phosphorylate Shaggy (homologue to mammalian GSK-3) has yet to 
be determined in vitro. Therefore, we looked at the ability o f DILK to phosphorylate 
Shaggy in vitro using fast performance liquid chromatography (FPLC) fractionated 
DILK samples for the in vitro kinase assay (Figure 5). Radiolabelled P Gamma ATP 
was added to purified DILK and Shaggy immunoprecipitated from Drosophila S2 cells 
and incubated for 30 minutes at 30°C. FPLC fractions previously collected show the 
highest amounts of DILK in fractions 6 and 9, with decreasing amounts in fractions 7, 
10, 8, and 5. However, the highest levels o f Shaggy phosphorylation were observed in 
lanes 7 through 9, with bands shifted upwards on the gel correlating to phosphorylation. 
A Shaggy immunoblot illustrates the presence o f consistent amounts o f Shaggy for each 
sample.
44
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 2.5. Phosphorylation o f Shaggy by DILK in vitro. Endogenous Shaggy was 
immunoprecipitated from Drosophila S2 cells with a polyclonal Sgg antibody. Equal 
volumes o f FPLC fractionated DILK samples (fractionated from cell lysate collected 
from Drosophila S2 cells transfected with DILK-V5 wt) were added to radiolabelled 32P 
ATP to observe their ability to phosphorylate Shaggy in vitro as determined by an in 
vitro kinase assay. FPLC fractions contain varying amounts of DILK. Western blots 
with Sgg polyclonal and V5 monoclonal antibodies illustrate the relatively equal 
amounts of Shaggy and the amounts o f DILK that were present in each sample.
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DISCUSSION
Signaling through the PI3’K pathway is responsible for many cellular events such as cell 
survival and apoptosis. Misregulation of these events at certain stages leads to 
tumourgenesis. Regulation o f these processes is carried out by the major effector 
molecule o f the pathway, PKB (reviewed Scheid and Woodgett, 2001; Scheid and 
Woodgett, 2003). Integrin linked kinase is an upstream regulator o f PKB and its role in 
the regulation o f numerous cellular pathways has been studied extensively in 
mammalian systems, and ILK itself has been characterized in many respects 
(Delcommenne et al., 1998, Troussard et al., 2003). However, Drosophila ILK 
characterization is substantially less complete, as is the determination of its functions in 
signaling pathways. Various signaling pathways collaborate to regulate cellular 
proliferation and growth, and the importance of ILK in each pathway separately, in 
addition to its ability to regulate crosstalk between pathways, is o f extreme importance. 
Sequence alignment o f DILK with human ILK showed 59% similarity at the protein 
level, and conservation of three conserved domains, the ankyrin, PH and kinase catalytic 
domains. Drosophila ILK contains 4 ankyrin repeats, as was also found in human ILK, 
and the four ankyrin repeats are conserved with only 10 amino acids differing from the 
consensus sequence. In general, the PH domain lacks primary sequence similarity 
between species and as a result, its structural homology cannot be assured, but 
similarities in structure lean toward a common function (reviewed in Rebecchi and 
Scarlata, 1998). The PH domain is conserved in Drosophila ILK with differences in 
only 3 residues required for binding to phosphatidylinositol lipid products. The DILK 
kinase domain exhibits similarity to the human ILK kinase domain with conservation at
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amino acid residue 356 (homologue to mammalian 359), which when mutated, renders 
the kinase domain o f ILK inactive, which is necessary for dominant negative studies. It 
is important to note that there is still speculation as to whether or not ILK exists as a 
kinase, as its catalytic domain differs from that of other typical kinase domains. 
However, mammalian ILK has been shown to behave as a bona fide  serine-threonine 
kinase, able to phosphorylate other substrates besides PKB/Akt, such as myosin light 
chain, myosin phosphatase target subunit, and myosin phosphatase inhibitors, PHI-1 and 
CPI-17 (Deng et al., 2001, Deng et al., 2002, Muranyi et al., 2002). In addition, the 
recent identification of a lipid-raft associated PKB serine 473 kinase, separate from 
PDK-1, PKB or ILK, antagonizes the PDK-2 theory, although its identity is still 
unknown (Hill et al., 2002).
Drosophila ILK is implicated as a PDK-2 in this study. Drosophila ILK is shown to be 
an effector molecule o f the PI3 ’K pathway, regulated in a PI3 ’K dependent manner. In 
vivo labeling o f DILK illustrates its ability to be regulated in a PI3’K dependent manner, 
as it is activated in response to insulin. The solidification of DILK regulation by the 
PI3’K pathway is important for the validity of other results, as it cannot phosphorylate 
effector molecules, such as PKB, if it is not part o f the PI3’K pathway. DILK functions 
in the PI3’K pathway to phosphorylate PKB substrate in vitro as well as in vivo. The 
PKB in vitro kinase assay shows that DILK can phosphorylate PKB, and that the 
phosphorylation is regulated in a PI3’K dependent manner. Insulin, a PI3’K stimulant, 
greatly increases PKB phosphorylation, consistent with mammalian studies 
(Delcommenne et al., 1998), whereas wortmannin, a PI3’K inhibitor, essentially negated
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it. Studies in mammalian systems have shown that ILK can act as a PDK-2, responsible 
for the phosphorylation of PKB at serine 473, resulting in complete activation o f PKB in 
conjunction with phosphorylation of threonine 308 by PDK-1 (Nicholson, and Anderson, 
2002, Delcommenne et al., 1998, Wu and Dedhar, 2001, Lynch et al., 1999, Persad et al., 
2001, Cruet-Hennequart et al., 2003). PDK-1 was initially proposed to also be 
responsible for stimulating the phosphorylation at the serine-473 residue (Balendran et 
al., 1999). This site was later found to be inducibly phosphorylated in PDK-1 knock-out 
cells, indicating the existence of a separate, distinct serine-473 kinase (Williams et al., 
2000). Our data support the mammalian results. We show that DILK is able to 
phosphorylate PKB on serine-505, the Drosophila homologue of serine-473, in vivo, 
thereby confirming its role as a PDK-2 molecule. Interestingly, it has been reported that 
the PI3’K pathway and PKB/Akt activation may not be affected in Caenorhabditis 
elegans ILK mutants {pat-4 (C.elegans homolog ILK) null mutant} and Drosophila ILK
911mutants (point mutation at W which introduces a stop codon and truncates the protein, 
and site-directed mutations; K219M, P358S and E359K) (Zervas et al., 2001,
MacKinnon et al., 2002).
In addition to its role in the PI3’K pathway, ILK also regulates effector molecules in the 
Wnt/Wg. We demonstrate that DILK is able to phosphorylate Shaggy, the homologue to 
mammalian GSK-3, in vitro using FPLC fractionated DILK, which coincides with 
findings in mammalian systems (Delcommenne et al., 1998). FPLC fractionation of 
DILK resulted in fractions that contained varying amounts o f DILK. Interestingly, 
fractions containing the most DILK did not directly parallel the highest levels o f Shaggy 
phosphorylation. This may be due to a dose dependent response with lesser amounts of
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DILK required for optimal phosphorylation, as higher amounts (i.e. saturation) of DILK 
may hinder phosphorylation due to masked binding sites or altered conformations. 
Alternatively, in vivo there are other proteins that bind to DILK, and interfere with its 
ability to phosphorylate Shaggy/GSK-3. These proteins, if bound, may not have the 
same effect on PKB and can explain the results obtained with GSK-3/Shaggy. However, 
the upshift in bands illustrates that Shaggy phosphorylation did occur, predominantly in 
lanes seven through nine. Unpublished work from our lab offers more evidence of 
DILK’s role in the regulation of Shaggy, as well as the role o f Dishevelled in regulating 
the Wnt/Wg pathway. Continued research will solidify the role o f DILK in the 
regulation of Shaggy and other effector molecules of the Wnt/Wg pathway. Speculation 
as to the existence o f two distinct pools o f mammalian GSK-3 creates the possibility of 
more complex regulation. GSK-3/Shaggy may exist as a molecule that is regulated by 
insulin through the PI3’K pathway to regulate glycogen synthase levels. However, a 
separate pool may exist that is regulated by the Wnt/Wg pathway thereby, regulating p- 
catenin levels. The ability of ILK to act as PDK-2, and regulate both pools is possible. 
Further work will decipher the actual components and design o f the Wnt/Wg, as well as 
the PI3’K pathway, and the complete understanding o f ILK as a PDK-2 molecule be 
achieved.
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CHAPTER THREE 
Identification of Candidate Drosophila Genes Regulated by Insulin and 
Wortmannin Using Microarray Technology 
Chapter Summary
Insulin is a known stimulant of the PI3’K pathway, increasing the activity o f both ILK 
and PKB and this action is negated by wortmannin, a PI3’K specific inhibitor. The 
effects o f both insulin and wortmannin have been studied extensively at the protein level. 
However, their ability to regulate genes at a transcriptional level has not been well 
documented. Microarrays determine the regulation o f a vast number o f genes 
simultaneously at the transcriptional level, allowing for the collection o f data and 
information that was otherwise unattainable using traditional approaches. In our current 
study, insulin and wortmannin, were shown to regulate a number o f genes in Drosophila 
S2 cells. Genes showing significant changes were then extracted from the resultant gene 
list. Two genes, Dream, and Tau, were selected. Dream was shown to be up-regulated 
by insulin and Tau was shown to be down-regulated by insulin, but up-regulated by 
wortmannin. Dream has been further analyzed by reverse transcription-polymerase 
chain reaction (RT-PCR) to confirm the microarray results.
INTRODUCTION
Microarrays have greatly enhanced gene expression studies as a tool capable of 
determining the transcriptional status of thousands of genes simultaneously, as well as 
exploitation in other disciplines (reviewed in Ali and Crawford, 2002). DNA 
microarrays are important in many areas of research, including the identification of
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new genes (Petkov et al., 2004), and the establishment o f downstream targets of 
characterized loci (Wells et al., 2003), as well as providing an excellent avenue to study 
gene regulation in both normal and diseased tissue (Alon et al., 1999, Kao et al, 2003, 
Schena et al., 1995). In addition, gene arrays can be employed to identify target genes 
that are up or down-regulated in response to stimuli. Insulin and wortmannin are 
external stimuli that regulate the PI3’K pathway antagonistically. At the protein level, 
insulin acts to increase the phosphorylation of numerous substrates, while wortmannin 
inhibits this event (Delcommenne et al., 1998, Persad et al., 2001). However, their 
internal downstream affects on gene expression has progressed slowly due to the 
limitations incurred by traditional approaches such as Northern blot analysis and reverse 
transcriptional polymerase chain reaction (RT-PCR). Microarrays are much more 
efficient, accurate and sensitive than either one of these single gene analysis methods. 
The difficulty of microarrays lies within the analysis o f the vast amounts o f data that is 
generated. Plodding through the data to extract relevant biological information is aided 
by numerous software programs that serve to normalize, filter and cluster important 
information (reviewed in Stevens and Ali, 2004 submitted). This chapter will illustrate 
the use of microarrays to determine genes that are regulated by insulin or wortmannin 
treatments in Drosophila S2 cells to further our understanding o f these two important 
stimuli. These results will enable us to draw conclusions about the regulation of 
numerous genes at the transcriptional level, thereby adding another dimension of 
understanding to what is already known about genes based on experiments at the protein 
level.
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MATERIALS AND METHODS 
Cell Culture
Drosophila Schneider 2 (S2) cells (ATCC) were grown in Schneider insect media 
(Sigma) containing 10% Fetal Bovine Serum (FBS) (Gibco) and 5% 
Penicillin/Streptomycin (P/S) (Gibco) and incubated at 22°C. Cells were split at a 
density of 5 x 106 cells/ml and 3 ml were plated into 6 well plates for subsequent 
treatments.
Trizol Total RNA Isolation
Drosophila S2 cells were grown to an approximate density o f 5 x 106 cells and treated 
with insulin (60 pg/pl) and wortmannin (200 nM) for 15 minutes. Control (no 
treatment), insulin and wortmannin treated cells were centrifuged at 700 rpms in a Jouan 
Br4i S40 centrifuge forlO mins at 4°C. The supernatant was removed and 1 mL of 
Trizol (Invitrogen) was added, pipetted up and down to lyse the cells, and incubated at 
room temperature for 5 mins to completely dissociate nucleoprotein complexes. Two 
hundred pis o f chloroform per 1 mL of Trizol was added to each sample and shaken 
vigourously for approximately 15 seconds and incubated at room temperature for 2-3 
mins. The samples were then spun at 12000g for 20 mins at 4°C. The top layer o f the 
three resultant layers contained the total RNA and was removed and placed into a new 
eppendorf tube. Five hundred pis of ice cold isopropanol per 1 mL of Trizol was added 
to precipitate the RNA. After gentle shaking to allow the isopropanol to distribute 
through the sample, the sample was incubated for 15 mins at room temperature, then 
centrifuged at 12000g for 10 mins at 4°C. The supernatant was removed and the RNA 
pellet was washed twice with 1 mL of 70% ethanol spinning it at 7500g for 5 minutes at
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4°C after each wash. The RNA pellet was then dried at room temperature for 
approximately 15 minutes and then dissolved in 50 pi of DEPC treated water and 
incubated for 10 minutes at 55-60°C. Five microlitres o f extracted total RNA was 
electrophoresed on a 1% agarose gel and an optical density (OD) reading at 260 nm was 
carried out to determine concentration.
Direct Labeling of Total RNA from Drosophila S2 Cells for Microarray Analysis
Drosophila 12K EST microarrays were obtained from the Canadian Drosophila 
Microarray Center. Approximately 60pg of total RNA isolated by the Trizol isolation 
method was used per sample. First strand cDNA synthesis, hybridization, and washing 
were carried out as outlined in the direct labeling protocol from the Canadian 
Drosophila Microarray Center ('http://www.flvarravs.com/download file/1. Sixty pg of 
total RNA from control, insulin, and wortmannin treated cells were reversed transcribed 
to synthesize first strand cDNA using Superscript™ Reverse Transcriptase (Invitrogen 
Life Technologies). Cyanine 3-dCTP and Cyanine5-dCTP fluors (Perkin Elmer) were 
incorporated into the cDNA and reciprocal labeling was performed to eliminate any bias 
in dye incorporation. After target precipitation, it was hybridized to the microarray chip. 
Ninety microlitres o f hybridization solution containing DIG Easy Hyb solution (Roche), 
yeast tRNA (Sigma), and calf thymus DNA (Sigma), was pipetted onto the chip and 
covered by a coverslip to ensure no air bubbles. Following hybridization at 37°C for 12- 
18 hours, the chip was washed with varying stringencies (room temperature IX SSC to 
remove the coverslip, 50°C IX SSC plus 0.1% SDS 3 times for 15 minutes each time at 
50°C, room temperature IX SSC for 30 seconds, and then room temperature 0.1X SSC
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for a few seconds), dried (5 mintues) and scanned using a Scanarray 4000 XL laser 
scanner and Scanarray Express™ software.
RT-PCR
RT-PCR was performed to further validate the microarray results. Five micrograms of 
total RNA from Drosophila cells was used for first strand cDNA synthesis in the 
presence o f RNasin (Promega) and Superscript™ Reverse Transcriptase (Invitrogen 
Life Technologies) as outlined in the enzyme manufacturer’s protocol (Invitrogen Life 
Technologies). Ten percent o f the first-strand reaction was used for PCR reactions. 
Primers were designed to specifically amplify genes o f interest (Dream) and the control 
gene (DILK). Polymerase chain reaction (PCR) conditions were determined empirically 
to find the linear range of amplification for Dream and reactions were conducted using 
Taq polymerase in 200 mM Tris-HCL (pH 8.4), 500 mM KC1, 1 mM MgCl2, 1 pi o f 10 
mM dNTPs, and 0.1 pi of 10 pM for the DREAM specific primers (5’- 
GAGCGGTTCGATAACAAGAAC-3 ’ and 5 ’ -TGGAATTTGGCGGTCTTTGGATTG- 
3’) and 1 pi o f 10 pM for the control DILK primers 
(5 ’ GGA ATT CAT GG AGG AC AT ATTCC ACT GGT GCCGC— 3 ’ and 
5’TCACTCGAGGCGGCGCATCTTCTCCAGAATGGGAAC— 3’). Dream 
amplifications were preceded by a 5 minute denaturation step at 95 °C, then immediately 
cycled 35 times at 95°C for 45 seconds, 57°C for 45 seconds, and 72°C for 1 minute.
The amplification o f DILK was preceded by a 5 minute denaturation step at 95 °C, then 
immediately cycled 27 times at 92°C for 1 minute, 55°C for 1 minute and 72°C for 2 
minutes. One tenth of each reaction was electrophoresed on a 1% agarose gel and 
visualized under UV light.
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Data Analysis
Acquired scanned images were quantified with Quantarray™ software and 
GeneTraffic™ software (Iobion Informatics) was used to analyze the data. Initially, 
spots of low intensity and high variability were filtered out using several parameters as 
outlined in Table 1.
Flag Parameters
y LEX.E to background intensity ratio less than '*
^  LEX.R to background intensity ratio less than
1 LEX.E intensity less than I times average background
^  LEX.R intensity less than J times average background
^  LEX.E intensity less than I 50
^  LEX.R intensity less than
Background Subtraction
p- Subtract local background values from spot intensities______________________
Table 3.1: Parameters used for the initial filtering o f low intensity spots. LEX.E 
represents the insulin or wortmannin treated spot intensities. LEX.R represents the 
control spot intensities.
Normalization was completed by LOWESS (Locally Weighted Scatter Plot Smoother) 
sub-grid method. The intensity values for each spot in a sub grid (repeated for every 
sub-grid on a chip) were normalized with respect to the data distribution in the 
immediate neighbourhood of a spot’s intensity. Therefore, normalization of dim spots is 
not influenced by the absolute values, or by the distribution pattern, o f any bright spots 
found on the chip (GeneTraffic™ User Manual, Iobion Informatics). Screened data was 
organized into gene tables which were then further filtered by comparing spot intensity 
ratios between the experimental and control chips (Table 2). These resultant filtered
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genes were hierarchically clustered to determine "distances" between the data elements 
as a means to determine similarity, the inverse of distance. Agglomerative methods 
which start with each item in its own cluster, and then successively combine the two 
closest clusters until all items are grouped together were used to cluster the data.
Gene Table Filters
i  * Remove genes with percentage o f values present lower than 100
| Remove genes without at least 1 observation(s) with absolute values o f log: ratio 
j greater than 1
Table 3.2: Parameters used for filtering of genes that showed no significant change in 
expression between control and treated cells across the various concentrations tested.
From the clustered data, genes of relevance were identified by setting the value of the
log2 ratio to be at least >1 and <-1 thus consequently exhibiting at least a 2 fold change
in expression (up or down-regulation respectively). Genes categorized with this fold
change had 3 o f 4 or 4 o f 4 possible spots “lit” (i.e. each gene has been spotted twice on
one chip, and these two spots on a separate chip were also reciprocally hybridized for
each treatment, for a total of 4 spots per gene).
RESULTS
Microarray Analysis: Image Acquisition and Quantification
Microarray chips were scanned with ScanArray Express™ and qualitative images were 
produced. A representative image of insulin treated Drosophila S2 cells, displaying one 
sub-grid o f the microarray chip, is shown in figure 3.1. These images represent 
qualitative results that provide a visual indication o f changes in gene expression as a 
result of the treatments. Images were scanned initially at a resolution of 50 microns to
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Figure 3.1. Representative qualitative images scanned at 5 microns using ScanArray 
Express™ are comprised of one sub-grid from reciprocally labeled insulin treated 
Drosophila S2 cells. Composite images are comprised of the independent Cyanine 3 
and Cyanine 5 images. Increase in gene expression as a result of treatment with insulin 
as compared to the control is represented by red spots, decrease in gene expression as a 
result o f insulin as compared to the control is represented as green spots and no change 
in gene expression is represented by yellow spots.
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3.1
Equivalent gene expression in 
insu lin  treated cells  and control 
cells.
Increased gene D ecreased gene
expression in > expression in
insu lin treated cells / insulin  treated cells
com pared to / / com pared to
control cells. / control cells.
Composite Control Cyanine 3 Insulin Cyanine 5
59
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
provide a visual template o f the chip allowing for selection of a smaller area composed 
of only the spot grid, which was then scanned at a resolution o f 5 microns producing a 
more accurate picture. Red spots indicate up-regulation o f gene expression in response 
to the insulin treatment. Green spots indicate down-regulation o f gene expression 
compared to the control, and yellow spots represent equal gene expression between the 
control and insulin treated cells. In the reciprocally labeled chips (image not shown) red 
spots indicate down-regulation of gene expression in response to the insulin treatment 
and green spots indicate up-regulation. Similar images were created upon scanning the 
wortmannin treated microarray chips (images not shown). The existence of numerous 
red and green spots in the scanned images illustrated the up or down-regulation of a vast 
number o f genes by the two treatments.
Hierarchical Clustering: Flagging, Filtering, Normalization and Data Reduction 
Insulin and wortmannin treatments were tested to detect any corresponding changes in 
gene expression. With the inclusion o f reciprocal hybridization, a total o f four 12K 
Drosophila chips were used for a total of approximately 96000 initial data points that 
could potentially exhibit detectable changes induced by insulin or wortmannin. Initial 
filtering and normalization based on the parameters shown in Table 3.1 drastically 
reduced the number o f data points and further selection o f these filtered genes based on 
the filtering parameters in Table 3.2 reduced the number even more to a manageable 
1151 data points. These 1151 data points were then hierarchically clustered (Figure 3.2) 
and genes that were up or down-regulated by insulin or wortmannin or both were 
identified as having at least a two fold change in gene expression. A schematic diagram 
illustrates the necessary steps required to reduce the initial data points to a manageable
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Figure 3.2. Data reduction by hierarchical clustering o f microarray data for insulin and 
wortmannin treatments. From the resultant gene list, two genes, Dream and Tau, were 
selected. Dream is shown in the first section o f clustered data with the lane enlarged to 
show up-regulation by insulin. Tau is shown in the second section of clustered data with 
the lane enlarged to show down-regulation by insulin and up-regulation by wortmannin.
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number o f regulated genes (Figure 3.3). Hierarchical clustering (2 fold change in gene 
expression and 3 or 4 spots “lit”) resulted in 30 genes that were up-regulated by insulin 
and 41 genes that were down-regulated by insulin, in addition to 70 genes that were up- 
regulated by wortmannin and 62 genes that were down-regulated by wortmannin (Figure 
3.3). From this list, two genes of interest, Dream and Tau, were initially selected from 
the clustered data due to relevance to the present study (GenBank accession numbers 
AA438962 and B I173687 respectively). Dream was shown to be up-regulated by 
insulin (1.05) and Tau was found to be up-regulated by wortmannin (1.07) and down- 
regulated by insulin (-1.94). RT-PCR was performed on Dream to validate the 
microarray results.
RT-PCR Verification of the Up-Regulation of Dream by Insulin
Verification o f the up-regulation of Dream by insulin, as was determined by the 
microarray experiment, was carried out using RT-PCR (Figure 3.4). RNA samples were 
reversed transcribed to cDNA and then amplified by specific primers to Dream. Dream 
was detected at a base level in untreated cells and this level was increased by treatment 
with insulin. A control containing no DNA showed no detectable band. Drosophila 
ILK was used as a loading and reaction control. It was amplified in relatively equal 
amounts in both the control and insulin treated cells.
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Figure 3.3. Schematic representation of data analysis resulting in the determination of 
genes that exhibited at least a 2 fold change in expression pattern. The necessary steps 
for the acquisition o f results from the microarray experiments using 12K Drosophila 
microarray chips include initial filtering and normalization, gene table filtering and 
hierarchical clustering. The genes obtained following the ‘secondary’ filtering were all 
clustered together resulting in gene lists for the regulation o f insulin and wortmannin. 
Examples of some o f the resulting genes that were regulated are included with their 
respective GenBank accession numbers.
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Figure 3.4. Verification of the up-regulation of Dream by insulin analyzed by RT-PCR. 
Dream was detected at a base level in the control sample. There was an increase in 
Dream in the insulin treated sample. RT-PCR was also carried out in the absence o f 
DNA as a control which showed no expression. DILK is shown as a control, and is 
equally expressed in all lanes shown as the inverse picture of the gel.
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DISCUSSION
Cell signaling involves a complex network of interactions that culminate in the nucleus 
resulting in changes in gene expression. These changes may be a reflection o f the 
morphological and physiological changes o f the cell. Microarray experiments determine 
changes in a cell at the transcriptional level and are set up to provide a high level of 
validity. Chips are reciprocally labeled to ensure that dye incorporation is not skewed 
by the samples, thereby resulting in any bias o f the results. Subsequently, software is 
used that incorporates many levels of filtering and normalization methods that further 
eliminate any irrelevant or misleading information. In this experiment, data elements 
were cDNA signals representing gene expression ratios (Cheng et al., 2003).
Calculation o f relative similarity is based on distances between data points. If two genes 
have similar expression profiles across the various treatments, the distance between 
them will be “small.” On the other hand, if  two genes have dissimilar profiles across the 
different treatments, the distance between them will be “large.” These distances are 
represented by a dendogram or “tree”. Interpretation o f the dendogram allows for 
extraction o f relevant biological data. The initial scanned images are the primary 
indication that the microarray experiment is successful, and provide a visual basis for 
determination of regulated genes (Figure 3.1). The consistent detection of a similar 
pattern o f hybridization on duplicate spots in a reciprocal fashion, increases the validity 
o f the presence o f the particular transcript and hence, the confidence in the output results. 
However, the scanned images provide no quantitative data and are therefore not useful 
for obtaining quantitative gene expression data. Upon filtering, normalizing, and 
clustering the data (Figure 3.2), these visual results are converted to quantitative results
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based on the ratio Log2, a representation of the ratio between experimental and control 
gene intensities expressed in a log scale of 2. Therefore, a value o f log2 =1 represents a 
2.0 fold higher expression o f the gene in chemically treated cells as compared to control 
cells.
From our results, we determined that 1151 genes were regulated by insulin and/or 
wortmannin, with at least a two fold change in gene expression, a great reduction from 
the initial 96000 data points (Figure 3.3). However, this number still seems high, and 
can be explained by direct and indirect effects o f insulin in cells. Direct stimulation 
results in the regulation o f genes that we expect to observe, while indirect stimulation 
may result in the regulation of numerous genes that are not yet known to be regulated 
directly or indirectly by insulin. Additionally, we only used one concentration of insulin 
in this study. Likely lower insulin concentrations, or altered treatment times, will be 
more specific activators or repressors of gene transcription and help in data reduction. 
The complexity o f cell signaling also lends itself to the high gene numbers. Regulation 
of one gene may knowingly or inadvertingly regulate another due to the intricate and 
numerous associations between cell signaling pathways.
Browsing the resultant gene list, we extracted two genes, Dream and Tau, due to interest 
and relevance to our study. We determined from the microarray results that Dream was 
up-regulated by insulin. RT-PCR was performed and confirmed that Dream is up­
regulated in response to the insulin treatment (Figure 3.4). Dream (downstream 
regulatory element antagonistic modulator) plays a critical role in pain modulation as a
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transcriptional repressor (Cheng et al., 2002). Insulin regulation o f Dream is novel and 
the significance remains to be determined. Recently, some studies have looked at the 
regulation o f sensory neurons in diabetes and the mechanism by which these neurons 
respond to insulin deficiencies (Calcutt et al., 2004, Toth et al., 2004). While Dream has 
not been linked to diabetes directly, its involvement in other neurodegenerative disorders 
and its regulation by insulin may suggest a possible role in the regulation of diabetes. It 
should be noted that the RT-PCR was not quantitative and therefore, the increase in 
expression o f Dream has not yet been determined. In the future, it would be 
advantageous to perform quantitative RT-PCR and also validate the data with Northern 
blot analysis.
Experiments are currently underway to verify the regulation o f Tau. Our microarray 
experiments illustrated down-regulation of Tau in response to insulin and up-regulation 
in response to the PI3’K specific inhibitor, wortmannin. Tau has been shown to interact 
with GSK-3, and is thus very interesting to our study. A splice variant o f GSK-3 p, 
GSK-3P2, was identified that contains a 13-residue insert in the kinase domain and has 
reduced activity to Tau, a microtubule-associated protein (Mukai et al., 2002). In 
addition, a proline-rich tyrosine kinase 2 (PYK2) may be responsible for GSK-3 tyrosine 
phosphorylation which, due to transient increases in intracellular calcium, subsequently 
increases the phosphorylation of Tau (Hartigan and Johnson, 1999, Hartigan et al., 2001). 
Characterization o f the Drosophila Tau homolog (Heidary and Fortini, 2001) showed a 
high degree o f conservation between the human and fly proteins and as a result, the fly 
model system will likely serve to provide insight into neuronal integrity and the
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consequences o f the loss o f this integrity in human diseases, such as Alzheimer’s disease. 
Tau has been implicated in Alzheimer’s disease which is a neurodegenerative disease 
characterized by the accumulation of P-amyloid and its own hyperphosphorylation 
(reviewed in Alvarez et al., 2002). Previous work shows that lithium inhibits Tau 
hyperphosphorylation and protects cultured neurons from cell death due to P-amyloid 
(Alvarez et al., 1999). Lithium is a known GSK-3 inhibitor, so it is likely that GSK-3 
plays a role in the progression o f Alzheimer’s disease. From our results, we can 
therefore speculate that insulin and wortmannin could also regulate the phosphorylation 
o f Tau through the regulation of GSK-3. In addition we show that they both affect the 
transcription o f Tau. This has implications in therapeutics as insulin and wortmannin, in 
addition to lithium, could be used in therapeutic trials to test their ability to ameliorate 
neurodegeneration in Alzheimer’s disease. Our studies therefore illustrate regulation of 
Tau at the transcriptional level which provides another dimension to the regulation of 
Tau at the post-translational level, as determined by the aforementioned studies. In a 
separate experiment, it was shown that Tau over-expression combined with 
phosphorylation by Shaggy exacerbated any neurodegeneration as a result o f Tau over­
expression (Jackson et al., 2002). In addition, manipulation o f other wingless signaling 
molecules downstream o f Shaggy, resulted in the modulation o f neurodegeneration 
induced by Tau in vivo (Jackson et al., 2002). Therefore, it is possible to speculate that 
insulin regulates the hyperphosphorylation of Tau through GSK-3, resulting in the 
regulation o f Alzheimer’s’ Disease, as well as regulating the transcription o f Tau, 
through yet unknown mechanisms (Figure 3.5).
71









Figure 3.5 -  Schematic of Tau regulation illustrating the mechanism of 
GSK-3 regulation of Tau protein levels in Alzheimer’s Disease and insulin 
regulation of Tau transcription, for which the mechanism has yet to be 
determined.
It is evident from our study that microarrays provide an important means to look at the 
regulation of gene expression on a global scale in Drosophila S2 cells. Initial gene lists 
can be condensed through further filtering and clustering, to include only those genes that 
are specifically regulated, and from this focused list, genes of interest or relevance can be 
selected and verified. We determined that Dream was up-regulated by insulin, for which 
further interpretation of its relevance in pain modulation and cell survival needs to be 
explored. In the future, further studies for the Tau gene will verify our findings and 
provide more insight into the mechanism of the regulation of Tau by GSK-3.
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CHAPTER FOUR
Directions for Future Study
In the present study, our goal was to further characterize Drosophila ILK both in vitro 
and in vivo. In addition, we hoped to identify genes that were regulated by different 
treatments using microarray methodology. These studies generated the following 
findings which were summarized in greater detail in chapters two and three:
1. Drosophila ILK encodes a conserved protein containing the three 
characteristic domains; ankyrin repeats, PH and kinase catalytic domains.
2. Drosophila ILK is phosphorylated in vivo and this phosphorylation is 
increased by insulin, in a PI3’K dependent manner.
3. Drosophila ILK is able to phosphorylate PKB/Akt in vitro in a PI3’K 
dependent manner, demonstrating increased phosphorylation in response to 
insulin, which is inhibited by wortmannin.
4. This phosphorylation of PKB by DILK occurs at serine 505, the Drosophila 
homologue of the mammalian serine 473 phosphorylation site, in vivo.
5. FPLC fractionated Drosophila ILK is able to phosphorylate substrate PKB- 
GST in vitro.
6. Insulin and wortmannin, PI3’K specific inducer and inhibitor respectively, 
illustrate regulation of numerous genes as was determined by microarray 
analysis.
7. Two genes o f interest, Dream shown to be up-regulated by insulin, and Tau 
shown to be down-regulated by insulin and up-regulated by wortmannin, 
were identified from the resultant microarray gene list. The up-regulation of 
Dream was further confirmed by RT-PCR.
FUTURE PROSPECTS
Although the findings o f the present studies have further characterized Drosophila ILK 
and determined genes that are regulated by insulin and wortmannin, several key 
experiments must still be performed to further validate our findings. The focus of this
73
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
thesis was to further characterize Drosophila ILK and carry out experiments that would 
solidify our hypothesis that DILK is a PDK-2 molecule. While our studies included an 
in vitro kinase assay that illustrated the ability o f endogenous DILK from Drosophila S2 
cells to phosphorylate substrate PKB, an in vitro kinase assay using bacterially 
expressed GST-DILK fusion protein still remains to be done. Bacterially isolated DILK 
illustrates that phosphorylation by DILK is in fact attributed to DILK, and not to some 
other protein bound in the S2 cells. I purified DILK-GST fusion protein from bacterial 
D.coli (BL-21) cells and completion of a kinase assay will further illustrate that DILK is 
able to phosphorylate substrate PKB in vitro.
The ability o f DILK to act in the Wnt/Wg pathway and regulate effector molecules of 
that pathway is also very important, when considering the cross regulation o f Wnt/Wg 
and PI3’K pathways. Our studies show that DILK is able to phosphorylate 
Shaggy/GSK-3, which correlates with mammalian findings (Delcommenne et al., 1998). 
However, there are numerous other molecules in the Wnt/Wg pathway that may also be 
regulated by DILK. Unpublished work from our lab determined that DILK and Dsh are 
able to interact, and that DILK is able to phosphorylate Dsh in vivo. Dishevelled 
deletion mutations determined that DILK and Dsh interact in the DEP domain of Dsh. 
Drosophila ILK deletion mutations must be created to determine the region o f DILK 
that interacts with Dsh (Figure 4.1). Primers were made for the deletion of each main 
region of DILK (Table 4.1).
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Z7-ILK Deletion Mutations
a) Wild-type D-ILK PH D om ain
3 Ankyrin-like R epeats Kinase Domain
b) Delete Ankyrin Repeats
c) Delete PH Domain
d) Delete Kinase Domain
Figure 4.1. Schematic illustrating the domains of DILK deleted via PCR to create DILK 
deletion mutations for subsequent determination of the interaction of DILK with Dsh.
Table 4.1. PCR primers for the deletion of the ankyrin, PH and kinase domains of 
Drosophila ILK
DILK  Ankyrin Deletions
5’ Primer 5'Ecor-l Ank
5 ’ CCGG A ATTC ATGGGCC A AGCC A AGCTTGTG3 ’
3’ Primer 3 ’ Xho-l
5” TCACTCGAGGCGGCGCATCTTCTCCAGAATGGGAAC3’
DILK  PH  Deletions
5’ Primer 5 ’ Ecor-l
5’GGAATTCATGGAGGACATATTCCACTGGTGCCGC3’ 
5 ’ Pst-1
5 ’ AAACTGC AGGACGC A ATCCCACTCCATTT AGCG 3 ’
3’ Primer 3 ' Pst-1
5 ’GCATTGGTTCTGCAGTTTGGCGTGGCCCTCTTT AGC3 ’ 
3 ' Xho-l
5’TCACTCG AGGCGGCGCATCTTCTCC AGAATGGGAAC3 ’
DILK  Kinase Deletions
5’ Primer 5" Ecor-l
5 ’GGAATTCATGGAGGAC AT ATTCCACTGGTGCCGC3 ’ 
5' Pst-1
5 ’ A A ACTGC AGCTTGTAG AA AAGAGCGGC
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The amplification o f selected domains was carried out by PCR and verified. The deleted 
regions must now be ligated back together and sub-cloned into pAC 5.1 A vector for 
subsequent transfection, and expression in Drosophila S2 cells. Co- 
immunoprecipitation with a Dsh specific antibody will pull down Dsh, and a subsequent 
immunoblot against DILK will illustrate regions o f DILK that bind to Dsh. Currently, 
primers were only designed for the deletion of the three important domains o f DILK; the 
ankyrin, PH and kinase catalytic domains. After initial determination o f the overall 
region that is responsible for binding to Dsh, further work should be carried out to 
pinpoint the actual amino acid residue(s) responsible for binding.
Microarray experiments were carried out to evaluate the effects o f insulin and 
wortmannin on nuclear gene expression using Drosophila S2 cells. Additional 
microarray experiments such as transfected DILK wt versus DILK kd (E359K mutant), 
or the effects o f insulin, pervanadate and wortmannin together, will determine the 
regulation of other Drosophila genes. In addition, the experiment with insulin and 
wortmannin created a gene list o f 1151 genes that were shown to be regulated by these 
treatments. In the future, this gene list could be further explored for data reduction using 
other filtering methods, and some candidate genes could be chosen. I initially chose 
Dream and Tau as candidate genes. Northern blot analysis or RT-PCR still needs to be 
completed to verify the microarray results obtained for Tau. Tau is a very exciting gene 
due to its involvement in Alzheimer’s disease and its relation to GSK-3. Mutations in 
presenilin 1 (PS1), which binds directly to, and regulates the phosphorylation of Tau, as 
well as GSK-3, as a Tau kinase, suggests that PS1 may regulate the interaction o f Tau
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with GSK-3B. It has been proposed that the increased association o f GSK-3(3 with 
mutant PS1 leads to increased phosphorylation of Tau (Takashima, 1998).
Finally, some experiments in this thesis were carried out using endogenous DILK 
immunoprecipitated with a polyclonal DILK antibody. Each o f these experiments was 
also attempted with transfected DILK wild-type or kinase dead (E359K mutant). 
However, transfection efficiency was a problem for some of the experiments. Therefore, 
completion o f studies using transfected DILK will further verify the ability o f DILK to 
act as a kinase. Transfections allow for the use o f DILK wt and DILK kd (E359K 
mutant), which offer another dimension to these studies. DILK kd (E359K mutant) acts 
as a dominant negative molecule and its use in future studies will demonstrate the effects 
of kinase deficient DILK.
Unpublished work from our lab illustrates other aspects o f DILK characterization. Work 
in this thesis illustrates additional experiments that help complete the characterization of 
DILK. However, some work still can be done to further show that DILK is indeed a 
kinase responsible for the phosphorylation of the main effector molecules in both the 
PI3’K and Wnt/Wg pathways. Knockout studies and siRNA interference in mammalian 
systems demonstrated an essential role for ILK in the regulation of both PKB and GSK- 
3 (Troussard et al., 2003). Similar experiments may be done in Drosophila to further 
demonstrate the essential role of DILK in the regulation of these effector molecules. In 
addition, experiments such as tryptic mapping or mass spectrometry will lead the 
researcher into more exciting areas of research and offer further evidence to support the 
findings in this paper.
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